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ABSTRACT OF DISSERTATION

STABILITY STUDIES OF MEMBRANE PROTEINS
The World Health Organization has identified antimicrobial resistance as one of the top
three threats to human health. Gram-negative bacteria such as Escherichia coli are
intrinsically more resistant to antimicrobials. There are very few drugs either on the market
or in the pharmaceutical pipeline targeting Gram-negative pathogens. Two mechanisms,
the protection of the outer membrane and the active efflux by the multidrug transporters,
play important roles in conferring multidrug resistance to Gram-negative bacteria. My
work focuses on two main directions, each aligning with one of the known multidrug
resistance mechanisms.
The first direction of my research is in the area of the biogenesis of the bacterial outer
membrane. The outer membrane serves as a permeability barrier in Gram-negative bacteria.
Antibiotics cross the membrane barrier mainly via diffusion into the lipid bilayer or
channels formed by outer membrane proteins. Therefore, bacterial drug resistance is
closely correlated with the integrity of the outer membrane, which depends on the correct
folding of the outer membrane proteins. The folding of the outer membrane proteins has
been studied extensively in dilute buffer solution. However, the cell periplasm, where the
folding actually occurs, is a crowded environment. In Chapter 2, effects of the
macromolecular crowding on the folding mechanisms of two bacterial outer membrane
proteins (OmpA and OmpT) were examined. Our results suggested that the periplasmic
domain of OmpA improved the efficiency of the OmpA maturation under the crowding
condition, while refolding of OmpT was barely affected by the crowding.
The second direction of my research focuses on the major multidrug efflux transporter in
Gram-negative bacteria, AcrB. AcrB is an obligate trimer, which exists and functions
exclusively in a trimeric state. In Chapter 3, the unfolding of the AcrB trimer was
investigated. Our results revealed that sodium dodecyl sulfate induced unfolding of the
trimeric AcrB started with a local structural rearrangement. While the refolding of
secondary structure in individual monomers could be achieved, the re-association of the
trimer might be the limiting factor to obtain folded wild type AcrB. In Chapter 4, the

correlation between the AcrB trimer stability and the transporter activity was studied. A
non-linear correlation was observed, in which the threshold trimer stability was required to
maintain the efflux activity. Finally, in Chapter 5, the stability of another inner membrane
protein, AqpZ, was studied. AqpZ was remarkably stable. Several molecular engineering
approaches were tested to improve the thermal stability of the protein.
KEYWORDS: Multidrug resistance, multidrug efflux pump, outer membrane proteins,
protein stability, AcrB
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CHAPTER I. INTRODUCTION
1.1 What are antibiotics? How do antibiotics work?
Antibiotics, also known as antibacterials, are compounds interfering with the normal
life process of bacteria or viruses, either killing them or stopping their reproduction.
The Greek word “antibiosis” was first introduced by Jean Paul Vuillemin, a French
bacteriologist, as a descriptive name of functions of these antimicrobial drugs in 1889.1
The “anti” means “against,” while the “biosis” means “life.” Selman Waksman, an
American microbiologist, later changed this term to “antibiotic” in 1942.2 Most
antibiotics are relatively small with the molecular mass less than 2000 atomic mass
units, which is around 200 times the size of a water molecule. Antibiotics were
originally discovered in organisms that display antibacterial actions. Nowadays, the
majority of the antibiotics are semisynthetic, variants derived from natural products for
specific clinical applications.3, 4

Based on their actions on microorganisms, antibiotics can be divided into two groups:
bacteriostatic agents that inhibit bacterial growth, and bactericidal agents that kill
bacteria. Bacteriostatic antibiotics slow down the growth of bacteria through disrupting
DNA replication and repair (e.g. quinolones5), protein biosynthesis (e.g. macrolides6)
or other cellular metabolism processes. Bactericidal antibiotics kill the bacteria usually
by interrupting bacterial cell wall biosynthesis (e.g. β–lactam antibiotics7), altering the
cell membrane permeability (e.g. polypeptide antibiotics8), or targeting essential
bacterial enzymes (e.g. rifamycins9). The target bacterial type and compound dosage
are also crucial to distinguish between bacteriostatic and bactericidal effects. The same
1

drug may be lethal to one type of bacteria, while only inhibitory to another. A high
dose of a bacteriostatic drug may also lead to cell death.

1.2 Threat of antibiotic resistance
Antibiotics are one of the most successful and powerful forms of chemotherapy in the
history of medicine. One of the famous antibiotics was penicillin discovered (more
accurately rediscovered) by the Scottish microbiologist Alexander Fleming in 1929.
The discovery and the successful usage of penicillin in the treatment of bacterial
infection ushered an era of antibiotics. Since then, numerous antibiotics have been
discovered and became the primary treatments of infectious diseases in humans,
animals, and plants. There is no doubt that the discovery and development of the
antibiotic drugs have saved hundreds of millions of lives and also brought tremendous
economic benefits to animal husbandry and agriculture.

However, overuse of

antibiotics soon began to cause problems. Only three years after the mass production
of penicillin, one strain of staphylococcal bacterium was found to be no longer
susceptible to penicillin. Today, especially in hospitals, there are bacterial strains
resistant to nearly all known antibiotics. This phenomenon was later referred to as
bacterial multidrug resistance (MDR). Antibiotics are no longer as effective at killing
bacteria as when they were first discovered. People are dying from diseases that used
to be readily treatable. According to the statistical results, antibiotic resistant bacteria
lead to the death of at least 23,000 people each year.10 Nowadays, the World Health
Organization has identified antimicrobial resistance as one of the top three threats to
human health.11

2

1.3 Mechanism of bacterial antibiotic resistance
The targets of most antibiotics are inside the bacterial cells. Bacteria gain resistance to
antimicrobials via five major mechanisms: a) active efflux of antibiotics through the
efflux pumps located in the cell membrane, b) enzymatic degradation of antibacterial
drugs, c) chemical alteration and inactivation of antimicrobials, d) reduction of the
permeability of the cell membrane, and e) mutation of the drug target or expression of
functionally redundant enzymes.12-14 Bacteria originally acquire their resistance genes
from genetic mutations that occur readily and spontaneously in bacterial cells.
Resistance genes stored in the bacteria genome or carried by small plasmids are passed
on to offspring through DNA replication and cell division. The latter can also be readily
shared among bacteria via cell conjugation, transduction, or transformation. The
combination of a rapid emergence and rapid sharing of the bacterial resistant genes
leads to the appearance and expansion of MDR bacterial strains.

1.4 Gram-negative and Gram-positive bacteria
While the majority of bacterial species are harmless or even beneficial to human, a
small faction are pathogenic. In general, bacteria can be divided into Gram-negative
and Gram-positive bacteria on the basis of a staining procedure by Danish
bacteriologist Hans Christian Gram in 1884.15 After staining, the violet color is washed
away by alcohol and leave cells with red/pink appearance under the microscope, since
the Gram-negative bacteria do not retain the crystal violet dye, while the Gram-positive
bacteria take up the dye and become purple/blue. This difference is ascribed to the
presence of a much thicker peptidoglycan layer in the Gram-positive bacteria cell wall
3

(Figure 1.1). Peptidoglycan is a mesh-like structure located between the inner and outer
membranes. It consists of alternating copolymers of N-acetylglucosamine and Nacetylmuramic acid. The copolymer chains are crosslinked by short (3-5) oligopeptides,
the N-terminal amine groups of which form amide bonds with the carboxyl groups of
N-acetylmuramic acid. The peptidoglycan layer strengths the bacterial cell wall and
helps counteract the osmotic pressure of the cell cytoplasm. The peptidoglycan layer
is 20-80 nm thick in the Gram-positive bacteria but only 1.5-15 nm in the Gramnegative bacteria.16 With such a thin layer of peptidoglycan, the Gram-negative
bacteria do not retain the violet dye in their cell wall.

Another distinctive feature of the cell wall of Gram-negative bacteria is the presence
of an outer membrane (Figure 1.1A). The outer membrane is located outside of the
peptidoglycan layer and provides extra barrier protection for the Gram-negative
bacteria. This feature results in the Gram-negative bacterium being intrinsically more
resistant to antibiotics than the Gram-positive bacterium.

4

Figure 1.1 Diagrams of cell envelopes of the Gram-negative (A) and Gram-positive
bacteria (B). The cell envelope of the Gram-negative bacteria comprises an inner
membrane (IM) and a cell wall including the periplasm and the outer membrane (OM),
while the Gram-positive bacteria contain an IM and a thick peptidoglycan-containing
cell wall.

The essential components of the cell wall and the IM are indicated:

phospholipids (PL, blue), peptidoglycan layer (PG, yellow), membrane proteins
(purple); lipopolysaccharides (LPS, green).

1.5 Mechanisms of drug resistance in Gram-negative bacteria
1.5.1 Role of outer membrane of Gram-negative bacteria in antimicrobial resistance
Compared with Gram-positive bacteria, Gram-negative bacteria are intrinsically more
resistant to antimicrobials. A survey of reported antibiotics of the natural origin
showed that more than 90% of the antibiotics that are active against the Gram-positive
bacteria are not effective against Escherichia coli.17 The lower sensitivity of the Gramnegative bacteria to antibiotic drugs is due to the extra protection from the outermost

5

semipermeable bacterial outer membrane (OM). The Gram-negative bacteria such as
E. coli contain two lipid bilayer membranes: the inner membrane (IM) and the OM,
separated by the periplasm (Figure 1.1A). These two membranes define the boundary
between the intracellular components of the bacterial cell and the outside world to
maintain an intrinsic homeostatic environment for cellular machinery.

The

composition of these two membranes is different: the IM is a phospholipid bilayer
containing α-helical transmembrane proteins (Figure 1.2A), and the OM is an
asymmetrical bilayer (where the inner leaflet facing to periplasmic space has a similar
composition to the IM, and the outer leaflet is composed of both phospholipids and
lipopolysaccharides (LPS)). Unlike the inner membrane proteins, the outer membrane
proteins (OMPs) adopt a β-barrel conformation and are thus termed β-barrel proteins
(Figure 1.2B).

6

Figure 1.2 Ribbon diagrams of the structures of the representative α-helical and β-barrel
membrane protein created using Pymol18. A. AqpZ monomer (PDB: 2ABM19). B.
OmpT (PDB: 1I7820)

The OM acts as a selective barrier and is composed of a highly hydrophobic lipid
bilayer with pore-forming proteins with specific size-exclusion properties embedded.
The targets of most antibiotics exist either in the periplasmic space or in the cytoplasm.
Therefore, the permeability of the membrane barrier plays an important role on the
susceptibility of the microorganism to antibiotics. Antibiotics cross the OM through
two pathways. Small hydrophilic antibiotic drugs, such as β-lactams, use porin
channels formed by OMPs (e.g. OmpC) to cross the OM. Macrolides and other large
hydrophobic or amphiphilic drugs cross the OM barrier by passive diffusion into lipid
bilayer.21

Many existing bacteria strains develop their resistance through the

modification of the phospholipid or LPS composition and the reduction of the porin
permeability in the OM. For instance, polymyxin B, a positive charged antibiotic,

7

penetrates the barrier via binding to the negative charged LPS, the outer leaflet of
OM.22

Polymyxin-resistant Salmonella typhimurium mutant strains decrease the

negative charges of LPS molecules by substitution of phosphate groups, located in the
core oligosaccharide and the lipid A component, by 4-amino-4-deoxy-L arabinose.
Such modification decreases the binding affinity of polymyxin to LPS molecules by
approximately 75%.23, 24 These mutants tolerate a concentration of polymyxin B up to
100 times higher than their parent strains. Certain drug tolerant mutants modify their
OMP composition to gain antimicrobial resistance.

Two porin-based resistance

mechanisms have been observed in clinical isolates: a) alterations of the OM profile,
including either severe reduction in expression or replacement of major drug-relevant
porins, and b) mutations to alter the porin specificity or reduce its permeability.21 In
summary, the existence of multiple drug-tolerant bacterial species (due to
modifications in the lipid or protein composition of the OM) highlights the importance
of the OM as a major mechanism of antibiotic resistance.

1.5.2 Role of active multidrug efflux transporters in antimicrobial resistance
Active multidrug efflux mediated by membrane transporters is another major bacterial
antibiotic-resistance mechanism noted in Section 1.3. The OM of the Gram-negative
bacteria blocks the entrance of a large number of antibiotics. However, it is not the
sole reason for the observed high level of resistance. Even with a diminished influx
rate (due to the presence of the OM), the concentration of many antibiotics in periplasm
could reach 50% of their external concentration in 10 to 30 s, due to the large surfaceto-volume ratio of the bacterial cell.25

Therefore, a second defense mechanism

8

involving the multidrug resistance pumps plays an important role in preventing drug
access to intracellular targets.

The multidrug transporters actively remove toxic

substances and antibiotics from the interior of the bacterial cell. Many transporters
have a broad range of substrates, and thus contribute to the resistance to multiple drugs.
There are five superfamilies of the transporters that utilize various energy source.26
These families include a) the major facilitator superfamily (MFS), b) the small
multidrug resistance protein family (SMR), c) the multidrug and toxic compound
extrusion transporters (MATE), d) the ATP-binding cassette superfamily (ABC), and
e) the resistance-nodulation-cell division superfamily (RND). A schematic illustration
of the coupling between the energy uptake and drug efflux of the bacterial drug efflux
pumps is shown in Figure 1.3. SMR, RND and MFS families utilize a proton gradient
to power transport activity, while the ABC and MATE pumps are driven by ATP
hydrolysis and sodium counter transport towards the cytoplasm, respectively.

9

Figure 1.3 Schematic illustrations of the cooperation between the energy uptake and
drug efflux for bacterial drug efflux pumps.27 Five major drug efflux pumps are
indicated: MFS, the major facilitator superfamily; SMR, the small multidrug resistance
protein; MATE, the multidrug and toxic compound extrusion transporters; ABC, the
ATP-binding cassette; and RND, the resistance-nodulation-cell division. The RND
transporter functionally associates with a membrane fusion protein (MFP) and an OMP
to form a drug efflux complex. Reprinted with permission from “Piddock, L. J. V.
Clinically relevant chromosomally encoded multidrug resistance efflux pumps in
bacteria, Clin. Microbiol. Rev. 19, 382-402.” ©2006 American Society for
Microbiology

Multidrug resistance pumps from several families of the transporters can be expressed
simultaneously in the Gram-negative bacteria cells and act synergistically to expel toxic
compounds. Multidrug efflux systems in the Gram-negative bacteria are reviewed by
10

Dr. Nikaido in one of his papers listed in Table 1.1.28 Among the multidrug efflux
transporters, the RND superfamily is the most clinically relevant antibiotic transport
system.29, 30 A systematic deletion of the multidrug resistant pumps in Escherichia coli
revealed that only the AcrAB-TolC (RND member) knockout strain displayed an
observable increase of sensitivity in 25 out of 35 tested antibiotics, whereas the removal
of other transporters demonstrated no alternation or only a minor influence on the drug
susceptibility.31 Despite their prominent role in antimicrobial resistance, few RND
transporters have been well characterized. So far, X-ray crystal structures of only four
RND efflux pumps have been reported. These are AcrB32 and CusA33 from E. coli,
MexB from Pseudomonas aeruginosa,34 and ZneA from Cupriavidus metallidurans
CH34.35 Because of the available high-resolution structures, AcrB and MexB are the
most extensively studied bacterial RND pumps.
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Table 1.1 Multidrug efflux systems in Gram-negative bacteria.28, 36-42
Transporter

Linker

OM channel

Organism1

Examples
substrates2

E. coli

Lipophilic
(TPP, EtBr)

of

SMR-type
EmrE

cations

MF-type
EmrB

EmrA

TolC

E. coli

CCCP, nalidixic acid,
thiolactomycin

RND-type
AcrB

AcrA

TolC

E. coli

MexB

MexA

OprM

P. aeruginosa

MexD

MexC

OprJ

P. aeruginosa

TC, CP, FQ, βlactams, Nov, Ery,
FuA, Rif, EtBr, AF,
CV, SDS, DOC
TC, CP, FQ, βlactams
(except
carbapenems), Nov,
EM, FuA, Rif
TC, CP, FQ

MexF

MexE

OprN

P. aeruginosa

CP, FQ, carbapenems

TC,CP,
β-lactams,
Ery, FuA, AF, CV,
TX, DOC
1. E. coli, Escherichia coli; P. aeruginosa, Pseudomonas aeruginosa; N. gonorrhoeae,
Neisseria gonorrhoeae
2. TPP, tetraphenylphosphonium; EtBr, ethidium bromide; TC, tetracycline; CP,
chloramphenicol; FQ, fluoroquinolones; Nov, novobiocin; Ery, erythromycin; FuA,
fusidic acid; Rif, rifampin; AF, acriflavin; CV, crystal violet; SDS, sodium dodecyl
sulfate; DOC, deoxycholate; TX, Tween X-100.
MtrD

MtrC

MtrE

N. gonorrhoeae

1.6 AcrAB-TolC drug efflux pump from E. coli
AcrAB-TolC is the main RND pump in E. coli that is responsible for extruding
detergents, dyes, bile salts, multiple classes of antibiotics, and even organic solvents.43
Its substrates are structurally and chemically diverse, linear, cyclic, aliphatic or
aromatic, charged or neutral, and drastically different in molecular weights.43
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Structures of the representative substrates of AcrAB-TolC are shown in Figure 1.4.
They

include

fluoroquinolones,

β–lactams,

tetracyclines,

macrolides,

and

oxazolidinones.

Figure 1.4 Representative substrates of the AcrAB-TolC efflux system. The system
accepts a broad range of substrates, including fluoroquinolones (ciprofloxacin), βlactam (e.g. oxacillin), tetracyclines (e.g. minocycline), macrolides (e.g. erythromycin),
detergent (dodecylsulfate), and organic solvents (hexane).
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Unlike the transporters from other families with only one IM element, all RND
members are functionally associated with two other components: membrane fusion
proteins in the periplasmic space and OMPs (Figure 1.3). Even though the crystal
structure of the assembled three components has not been determined yet, a model has
been established using the high-resolution crystal structures of three separated
components, and tested by cross-linking studies.44, 45 In the AcrAB-TolC efflux system,
AcrA is the periplasmic linker that facilitates the interaction between the IM transporter
AcrB and the OM channel TolC to form the entire export system (Figure 1.5).43 The
tripartite organization allows the pump to expel its substrates all the way out of cells
bypassing accumulation in the periplasm.
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Figure 1.5 Structure model of the AcrAB-TolC efflux system of Gram-negative E.
coli.27 The system is composed of AcrB (IM component, in green color), TolC (OM
component, red), and AcrA (periplasmic linker, blue). Reprinted with permission from
“Piddock, L. J. V. Clinically relevant chromosomally encoded multidrug resistance
efflux pumps in bacteria, Clin. Microbiol. Rev. 19, 382-402.” ©2006 American Society
for Microbiology

Structures of three proteins constituting the tripartite AcrAB-TolC efflux system were
shown separately in Figure 1.6. AcrA is a membrane fusion protein consisting of three

15

periplasmic domains (α-helical hairpin, lipoyl domain, and β-barrel domain) and an Nterminal lipid anchor attached to the IM (Figure 1.6C).40 The N-terminal lipid linker
is not believed to be essential for drug efflux activity.46 AcrA binds to TolC through
its α-helical hairpin, whereas the exact interface of the adaptor with AcrB remains
unknown.45, 47 The oligomeric state of AcrA also remains to be determined, which
could be a trimer or a hexamer. TolC is the OM component of the system. TolC trimer
forms a channel of 35Å diameter through its β-barrel domain in OM and extends its αhelical domain into the periplasm to form a conduit that accepts the substrate extruded
from AcrB (Figure 1.6A).48 TolC is not exclusively used by AcrAB to transport
substrates across the OM. It is also recruited by other RND efflux systems in E. coli
(MdtEF and MdtAB for instance) as an exit duct.49
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Figure 1.6 Structures of three proteins constituting the tripartite AcrAB-TolC efflux
system (AcrA, AcrB and TolC) created using Pymol.18 Dimensions and domains of
each component are indicated. A. Structure of TolC trimer (created from 1TQQ.pdb50).
B. Structure of AcrB trimer (created from 2GIF.pdb51 ). C. Structure of AcrA monomer
(created from 2F1M.pdb52).

AcrB is the actual active pump of this efflux system that utilizes the inward flow of
proton across the IM to drive substrate efflux. The crystal structure of AcrB has long
been known.32, 53 It is composed of three identical 1,049-residue subunits with the
symmetry axis perpendicular to the membrane plane (Figure 1.6B). The structure of a
single AcrB subunit is diagrammed in Figure 1.7.

Each subunit contains 12

transmembrane helices (THs) and a periplasmic domain with a mixed secondary
structures and is formed by two long loops between TH 1 and TH2 and between TH 7
and TH8. The AcrB trimer is divided into three domains: a transmembrane domain, a
pore domain and a TolC docking domain. The proton translocation is related with
residues Asp407, Asp 408, and Lys940 located in the transmembrane domain, while
the substrate transportation and TolC interaction occur in the pore domain and the TolC
17

docking domain, respectively. Substrates of AcrB are captured in the periplasm and
the outer leaflet of the IM, then transported through the binding pocket and finally to
the AcrB funnel that connects AcrB to TolC.54 Details of substrate transport in AcrB
will be discussed in the following section.
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Figure 1.7 Structure of a single AcrB subunit.32 A. Topology diagram of one AcrB
subunit. The subunit is divided into N-terminal half (dark blue) and C-terminal half
(light blue). Secondary structure elements are indicated: TM, transmembrane helices;
Nα and Nβ, helices and strands, respectively in the N-terminal half; Cα and Cβ, helices
and strands, respectively in the C-terminal half; Iα, a helix attached to the cytoplasmic
surface of the membrane. Dotted lines represent disordered polypeptide segments. The
pore domain is divided into four subdomains: PN1, PN2, PC1 and PC2, while the TolC
docking domain is divided into two parts: DN and DC. B. Crystal structure of one
AcrB subunit (side view). Subdomains are depicted in different colors: DC (purple),
DN (yellow), PN1 (cyan), PN2 (green), PC1 (red), PC2 (orange), N-terminal
transmembrane segment (magenta), C-terminal transmembrane segment (blue), and Iα
(dark). Reprinted by permission from Macmillan Publishers Ltd: Nature (Murakami,
S., Nakashima, R., Yamashita, E., and Yamaguchi, A. Crystal structure of bacterial
multidrug efflux transporter AcrB, 419, 587-593) ©2002
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1.7 A conformational cycling model of AcrB for drug transport
AcrB is an obligate trimer that exists and functions exclusively in a trimeric state. The
structure of AcrB was first solved as a homotrimer.32, 53 However, later studies on the
crystal structure of AcrB indicated that AcrB actually functions in an asymmetric trimer
form and suggested a conformational cycling model for drug transport.51, 55 According
to the current model, within the asymmetric AcrB, each monomer adopts a different
conformation with various substrate affinities: loose (L), tight (T), and open (O) states
corresponding to the access, binding and extrusion of substrate activities. The stepwise
AcrB-catalyzed drug transport is shown in Figure 1.8. The substrate enters the lower
part of the periplasmic cleft (a large lateral indentation defined by the PC1 and PC2
subdomains54) and loosely binds to the monomer in the L conformation. The substrate
is subsequently directed to a high-affinity deep binding pocket (consisting of multiple
phenylalanine residues, such as Phe178, Phe610, Phe615 and Phe617). This step is
associated with a conformational change of monomer from L to T. Finally, the substrate
is extruded through the funnel towards TolC during the transition from T to O state.
Subdomains PC1 and PC2 close the lateral access to prevent the backsliding of the
drug.56 After releasing the substrate, the monomer is reset to the L conformation and
ready for drug uptake. The entire process is coupled with proton translocation, which
drives the transition between different states.
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Figure 1.8 Schematic representation of the AcrB alternating site functional rotation
mechanism as described in the text.57 Three conformations of AcrB monomer are
depicted in different colors: L (blue), T (yellow) and O (red). Substrate shown is
acridine. A. Side view of AcrB and substrate binding. AcrA and TolC are indicated in
light green and light purple colors, respectively. B. Wheel view of AcrB trimer during
the operation. Reprint from Biochimica et Biophysica Acta, 1794, Pos, K. M. Drug
transport mechanism of the AcrB efflux pump, 782-793 ©2009 with permission from
Elsevier.

1.8 A brief summary of the thesis work
As discussed above, two major mechanisms, the protection of the OM and the active
efflux of the multidrug transporters, confer potent multidrug resistance to the Gramnegative bacteria. My research focuses on the folding, assembly, and stability of the
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membrane proteins involved in those two bacterial cellular defense mechanisms. In
Chapter 2, the crowding effect on the refolding mechanism of two model OMPs, OmpA
and OmpT, was examined. Our results indicated that the refolding of OmpA was
slowed down by the crowding, while that of OmpT was hardly affected. Full length
OmpA slowed down its refolding rate to ensure correct folding under the crowded
condition, which is mediated by the periplasmic domain. In Chapter 3, the unfolding
of the trimeric AcrB induced by SDS and urea was investigated using intrinsic
fluorescence and circular dichroism spectroscopy. Our results suggested that unfolding
of the trimeric AcrB started with a local structural rearrangement. While the refolding
of secondary structure in individual monomers could be achieved, the re-association of
the trimer might be the limiting factor to obtain folded wild type AcrB. In Chapter 4,
I investigated the relationship between the stability and transporter activity of the AcrB
trimer. A non-linear correlation between the two was determined, in which a threshold
value was required to maintain the efflux activity of the transporter. To extend the
work on the membrane protein stability, I studied another inner membrane protein
Aquaporin Z (AqpZ). In Chapter 5, several molecular engineering approaches were
tested to increase the thermal stability of AqpZ.

Copyright © Cui Ye 2014
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CHAPTER II. EFFECT OF CROWDING BY FICOLLS ON OMPA AND
OMPT REFOLDING AND MEMBRANE INSERTION

Part of this chapter are taken from “Effect of crowding by Ficolls on OmpA and OmpT
refolding and membrane insertion”, 2013, Protein Sci. 22, 239-245

2.1 Introduction
Gram-negative bacteria such as E. coli contain two layers of membranes, separated by
the periplasmic space. Proteins embedded in these two membranes are different. While
the IM contains mainly α-helical transmembrane proteins, the OMPs form β-barrels.58,
59

OMPs serve various functions that are crucial to cell viability and activity, including

structural support, catalysis, and are involved in both active transport and passive
diffusion.60, 61 The biogenesis of OMPs is a complicated process (Figure 2.1).62-64
Briefly, all proteins are originally synthesized on ribosomes in the cytosol. OMP
protein precursor containing an N-terminal signal peptide is first translocated across
the IM through translocons (for instance, SecYEG translocation machinery). Once
reaching the periplasm, the leader signal peptide of OMP is removed by signal
peptidase. Molecular chaperones including Skp, DegP, and SurA stabilize OMPs in
the periplasm and assist their folding and insertion into the OM through the β-barrel
assembly machinery (BAM) to form the β-barrel structure.65-68
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Figure 2.1 The diagram of the biogenesis of OMPs as described in the text.69 From
“Hagan, C. L., Kim, S., and Kahne, D. (2010) Reconstitution of Outer Membrane
Protein Assembly from Purified Components, Science 328, 890-892.” Reprinted with
permission from AAAS

Most current understanding of OMP folding has been obtained from in vitro studies
conducted in dilute buffer solution.70-76 However, the actual bioproduction of OMPs
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occurs in a very crowded environment. The intracellular space is filled with a variety
of macromolecules including proteins, polysaccharides, nucleic acids, and lipids.77, 78
The periplasm has been described as a “gel-like” environment with macromolecules
occupying ~30% of the overall space.79 Under this crowded condition, proteins may
behave differently than in dilute solution. This phenomenon is called the
“macromolecular crowding” effect, first proposed by Minton and coworker in 1981.80
It is later summarized by Minton as “the influence of volume exclusion upon the
energetic and transport properties of macromolecules within a crowded or highly
volume-occupied medium”.81 The impact of macromolecular crowding on biological
systems is attracting increased attention from the research community in recent years.
Studies on soluble proteins have shown that the crowding condition affects the stability
of proteins and alters their unfolding/refolding processes.82-87

In this study we

investigated the macromolecular crowding effect on the refolding and membrane
insertion of OMPs, using OmpA and OmpT as model proteins (Figure 2.288, 89) and
Ficoll 70 as crowding agent to mimic the crowded condition in the periplasm. Ficoll
70 is a sucrose polymer that has been used as an inert co-solute in many studies
investigating the crowding effect on protein properties.90-92
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Figure 2.2 Crystal Structures of OmpA88 (1QJP.pdb) and OmpT89 (1I78.pdb) viewed
from the side. The oval in OmpA represents its periplasmic domain, the structure of
which remains unknown.

2.2 Materials and Methods
2.2.1 Protein cloning, expression, and purification
Genes encoding OmpA, OmpT, and the transmembrane domain of OmpA (OmpA171)
without the signal peptide were amplified from the genomic DNA of E. coli K-12 and
inserted into plasmid pET22b, which introduced a six-histidine tag at the C terminus
of the protein. Primers used in the construction of expression plasmids are listed in
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Table 2.1. Plasmid containing the OMP gene and the ampicillin resistance marker was
then transformed into E. coli strain ER2566 for protein expression. Cells were cultured
at 37 °C in Lysogeny Broth media (1% tryptone, 0.5% yeast extract, 1% NaCl)
containing 100 g·mL-1 ampicillin to an OD600nm of approximately 0.6. The expression
of protein was induced by the addition of isopropyl-beta-D-thiogalactopy-ranoside
(IPTG) to a final concentration of 1 mM. After three hours, cells were harvested by
centrifugation at 7,000 g for 10 min at 4 °C. Cell pellets were stored at -20 °C for
purification next day.

Table 2.1 Primers used in the construction of plasmids containing OmpA, OmpT and
OmpA171. Restriction enzyme digestion sites are underlined.
OmpA
F: 5’-GCTCATATGGCTCCGAAAGATAACACCTGGTAC-3’
R: 5’-GCCTCGAGAGCCTGCGGCTGAGTTACAACGTC-3’
OmpT
F: 5’-GACATATGTCTACCGAGACTTTATCGTTTACTC-3’
R: 5’-GACTCGAGAAATGTGTACTTAAGACCAGCAGTAG-3’
OmpA171
F: 5’-GACATATGGCTCCGAAAGATAACACCTGGTAC-3’
R: 5’-AACTCGAGACC GAA ACG GTA GGA AAC ACC-3’
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The purification procedures for OmpA and OmpT were the same. Briefly, cell pellets
were resuspended in a lysis buffer (30 mM Tris base, 0.5 M NaCl, 1% Triton, 1 mM
phenylmethylsulfonyl fluoride (PMSF), pH 8.0) and then sonicated on ice for 15 min
with 10 sec on/off intervals to lyse cells. After centrifugation at 10,000 g for 30 min at
4 °C, the supernatant containing soluble proteins was discarded, while the pellet was
dissolved in the sonication buffer (30 mM Tris base, 0.5 M NaCl, 6 M guanidine, pH
8.0) and sonicated again with the same setting.

After sonication, the mixture was

centrifuged at 25,000 g for 20 min at 4 °C. The supernatant containing dissolved OMPs
was loaded on a Ni-nitrilotriacetic acid column, washed with a buffer containing a low
concentration of imidazole (30 mM Tris base, 0.5 M NaCl, 8 M urea, 20 mM imidazole,
pH 8.0) and eluted using an elution buffer (20 mM sodium acetate, 0.5 M NaCl, 8 M
urea, pH 4.0). The pH of protein solution was adjusted to 8.0 after elution. OmpA171
was purified as described with slight modifications.73

Briefly, cell pellets were

resuspended in the lysis buffer, sonicated on ice, and then centrifuged to obtain the
inclusion bodies as described for the purification of OmpA and OmpT. The inclusion
bodies were washed twice with 20 mM sodium acetate, 0.5 M NaCl, 2 M urea, 1%
Triton, pH 8.0 followed by centrifugation (2900 g, 30 min, 4°C). Before refolding,
OmpA171 pellet was dissolved in a buffer containing 8 M urea (2 mM
Ethylenediaminetetraacetic acid (EDTA), and 10 mM borate, pH 10.0).

Purified protein was analyzed using sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE) and visualized by staining with Coomassie Blue.
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Concentrations of all three proteins were determined using Pierce BCA Protein Assay
Kit (Thermal Scientific INC., TX).

2.2.2 Preparation of small unilamellar vesicles
Small unilamellar vesicles (SUVs) were prepared as described with slight
modifications.73 E. coli Lipid Total Extract (Avanti Polar Lipids, INC.) dissolved in
chloroform was dried to form a thin film in a glass vial under a gentle stream of nitrogen.
The lipid film was then placed under vacuum at room temperature overnight to remove
residual solvent. Prior to the insertion studies, the dry lipid film was hydrated in a
borate buffer (10 mM Na-borate, 2 mM EDTA, pH 10) at a lipid concentration of 3.2
mg·mL-1 at 4°C overnight. An appropriate amount of Ficoll 70 (GE Healthcare, PA)
were added to the borate buffer during hydration when indicated. The SUV suspension
was prepared by sonicating hydrated lipid solution for 50 min using a Branson digital
Sonic Dismembrator at 50% pulse cycle in an ice/water bath. The SUV solution was
equilibrated overnight at 4°C and used within 48 hours after preparation. The size of
SUVs in solutions containing different amount of Ficoll 70 was determined using a
Wyatt DynaPro Dynamic Light Scattering (DLS) System.

2.2.3 Folding and membrane insertion of OMPs
OMP refolding experiments were performed following a published protocol.73
Refolding was initiated by rapidly diluting a stock solution of OMP (in 8 M urea) into
a buffer solution containing 3.2 mg·mL-1 SUV (1 M urea, 2 mM EDTA, 10 mM borate,
pH 10.0, in the presence or absence of Ficoll 70) at 37°C to a final concentration of 4
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M OMP (25 M for OmpA171). After folding was initiated, at different time points
small aliquots of the mixture were collected, quenched by adding SDS gel-loading
buffer, and kept on ice. At the last time point, two aliquots were taken – one was treated
similarly to the other samples, and the other boiled for 5 min and used as a control.
Samples were then analyzed by SDS-PAGE on a 12% gel. After electrophoresis, gels
were stained with Coomassie Blue. Gel images were analyzed using software ImageJ
to obtain the percentage of refolding.93

2.2.4 Residual structure of OMPs detected by far Ultraviolet (UV) Circular Dichroism
(CD) spectroscopy and fluorescence spectroscopy
The OMP stock solution dissolved in a buffer containing 8 M urea (30 mM Tris base,
0.5 M NaCl, pH 8) was quickly diluted using the same buffer without urea to a final
urea concentration of 1 M and protein concentration of 0.375 mg/mL, and then scanned
from 210 nm to 250 nm. The same sample was recovered for measurement of its
fluorescence spectrum exciting at 280 nm and scanning the emission from 320 nm to
450 nm. The CD and fluorescence emission measurements were performed by Ms.
Qian Chai.

2.2.5 Residual structure of OMPs detected by limited protease digestion experiment
Effect of crowding on protease activity. Standard protease digestion assay was used to
determine the protease activity of trypsin and chymotrypsin

94

. Specifically, a buffer

solution containing synthetic small molecule substrate of different concentrations was
incubated in UV/vis spectrophotometer at room temperature for three to four minutes
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until its absorbance stabilized. Protease was then added into the solution to a final
concentration of 3 µg/mL and the solution was mixed thoroughly. The increase of
absorbance was recorded at the indicated wavelength over time. Trypsin activity was
monitored using Nα-p-toyl-L-arginine methyl ester hydrochloride (TAME) as the
substrate at 247 nm in a buffer containing 0.0046 M Tris·HCl, 0.0115 M calcium
chloride, pH 8.1. The reaction rate was calculated using the following equation:

Rate ( AU / mg ) 

A247 / min  V (mL)
540  M (mg )

in which ΔA247 is the absorbance change at 247 nm, V is the total reaction volume in
milliliter, M is the amount of trypsin in the reaction mixture in milligram, and 540 is
the extinction coefficient of TAME at 247 nm. Chymotrypsin activity was monitored
using N-benzoyl-L-tyrosine ethyl ester (BTEE) as the substrate at 256 nm in a buffer
containing 0.08 M Tris·HCl, 0.1 M calcium chloride, pH 7.8. The reaction rate was
calculated using a similar equation:

Rate ( AU / mg ) 

A256 / min  V (mL)
964  M (mg )

in which ΔA256 is the absorbance change at 256 nm, V is the total reaction volume in
milliliters, M is the amount of chymotrypsin in the reaction mixture in milligrams, and
964 is the extinction coefficient of BTEE at 256 nm.

Limited protease digestion of protein substrate. Digestion was initiated by mixing
protein substrate with protease in the digestion buffer at the room temperature. The
mass ratio of substrate to protease was adjusted for different proteins to get a clear
digestion pattern on SDS-PAGE gel. For trypsin digestion, the substrate to protease
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mass ratio for all proteins was 100. For chymotrypsin digestion, the mass ratio for
Bovine Serum Albumin (BSA) (Bioworld, OH), OmpA, and OmpT was 33, 200 and
100, respectively. The concentration of all substrate proteins was constant at 0.3
mg/mL. BSA was used as a control protein substrate to examine the effect of crowding
on the activity of the proteases. After the reaction started, small aliquots of reaction
mixture were removed and quenched by the addition of PMSF and SDS-gel loading
buffer. Samples were boiled in a water bath for 5 min before analyzing by 12% SDSPAGE. After electrophoresis, gels were stained with Coomassie Blue. Images of gels
were analyzed by ImageJ software.

2.3 Results
2.3.1 Effect of the crowding condition on the rate of membrane insertion of OmpA and
OmpT
To investigate the crowding effect on the folding and membrane insertion of OMPs,
we monitored refolding and membrane insertion of OmpA and OmpT in SUV solution
in the absence or presence of Ficoll 70. Three different Ficoll 70 concentrations, 5%,
10%, and 20%, were used in this experiment. At concentrations above 20% the high
viscosity of the solution drastically decreased the efficiency of sonication and thus the
formation of liposomes. To examine the effect of crowding on liposome formation,
sizes of SUV vesicles prepared in the absence or presence of Ficoll 70 were measured
using DLS. Sizes of SUVs were in the range of 10 to 100 nm, and Ficoll 70 at
concentrations up to 20% had little effect on the size distribution of the SUVs (Figure
2.3).
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Figure 2.3 Dynamic light scattering results of small unilamellar vesicle in the absence
(triangles) and presence (5%, diamonds; 10%, circles; 20%, squares) of Ficoll 70.

Folding and membrane insertion of OMPs were followed by SDS-PAGE. Previous
studies have shown that the folded and unfolded OMPs usually migrate differently on
SDS polyacrylamide gel.73 As shown in Figure 2.4A, after Coomassie blue stain, two
bands were clearly visible on the gel. The bands with lower and higher apparent
molecular weight were the folded and unfolded species, respectively. Intensities of
bands were quantified using software ImageJ, and converted into fraction of folded
protein through the following equation:

Folding % 

IF
100%
IT

in which IF and IT are the intensities of the bands corresponding to the folded OMP
at different time and the total OMP, respectively. Several studies have shown that the
folding kinetics of OMPs can be fitted using a single exponential equation.71, 73, 95
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Similarly, we fitted the folding data over time using a single exponential equation
(Figure 2.4B):

y  y0  Ae  kt
where y is the folded fraction at certain time point, t is the time, and y0 is the fraction
folded as time approaches infinity. The rate constant k could be obtained through fitting.
The rate constants of refolding obtained in the presence or absence of Ficoll 70 were
shown in Table 2.2. We found that at low Ficoll 70 concentration (5%), little effect
could be observed on the refolding rate of OmpA. The rate constant decreased
significantly in 10% and 20% Ficoll 70. However, Ficoll 70 at a concentration as high
as 20% had little effect on the refolding rate of OmpT, while the overall folding
efficiency decreased with the increase of Ficoll 70 concentration (Figure 2.4B).

Table 2.2 Refolding rate constants (min-1)
OMP

No Ficoll 70

5% Ficoll 70

10% Ficoll 70

20% Ficoll 70

OmpA

0.016±0.004

0.019±0.005

0.0049±0.0001

0.0020±0.0002

OmpT

0.20±0.04

0.14±0.03

0.24±0.03

0.18±0.02

OmpA 171

0.014±0.002

/

/

0.028±0.002
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Figure 2.4 OMP refolding and membrane insertion. A. Representative SDS-PAGE
images of OmpA and OmpT refolding. BS: boiled sample. M: protein molecular weight
marker. For OmpA, lanes 1 to 9 correspond to 0, 10, 20, 40, 80, 160, 320, 640, and
1410 min of incubation. For OmpT, lanes 1 to 11 correspond to 0, 30, 60, 120,180, 240,
300, 360, 540, 900, and 1440 s of incubation. B. Kinetics of OmpA and OmpT refolding,
in buffer (triangles), 5% Ficoll 70 (diamonds), 10% Ficoll 70 (circles), and 20% Ficoll
70 (squires). Data were averages of three independent experiments and fitted to a single
exponential equation.
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2.3.2 The refolding and membrane insertion mechanism of OMPs
Kleinschmidt and coworkers proposed a model describing the folding and membrane
insertion mechanism of a β-barrel membrane protein in several steps (Figure 2.5). 96, 97
Refolding occurs spontaneously when the unfolded OMPs dissolved in 8 M urea are
diluted into the refolding buffer in the presence of the model phospholipid membrane.
The first step involves a rapid hydrophobic collapse in which a completely denatured,
unstructured polypeptide folds into a conformation with a detectable residual structure
(water-soluble intermediate). This step is too fast to detect on the time scale of seconds.
The next step is much slower and occurs in the minute time scale, which can be easily
monitored by fluorescence spectrometry. In this step, the water-soluble intermediate
interacts and absorbs to the surface of the lipid bilayer, accompanied by the structure
rearrangement on the surface of the lipid bilayer. The last step is the formation of the
secondary and tertiary structures of OMP. It is an even slower step, usually finishes in
minutes to hours. The refolded OMPs are fully functional with native-like structures,
as revealed by FT-IR spectroscopy,98 CD spectroscopy,

99

and single channel

conductivity measurements.100

To understand the mechanism underlying the different crowding effect on the refolding
and membrane insertion of OmpA and OmpT, we examined the crowding effects on
the structures of water-soluble intermediate of OMPs using CD spectroscopy, intrinsic
fluorescence, and protease digestion.
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Figure 2.5 Scheme of refolding kinetics of OMPs in vitro.97 U represents unfolded
protein; A, aggregation state; Iw, water-soluble state; IM, intermediate state; N, native
structure of protein. K represents the rate constant of each step. Reprinted with
permission from “Kleinschmidt, J. H., and Tamm, L. K. Folding Intermediates of a βBarrel Membrane Protein. Kinetic Evidence for a Multi-Step Membrane Insertion
Mechanism, Biochemistry 35, 12993-13000.” ©1996 American Chemical Society

2.3.3 Crowding had similar effect on the secondary structures of OmpA and OmpT as
revealed by far UV CD spectroscopy
The far UV CD spectrum is routinely used to assess the secondary structure content of
the proteins. The spectrum of the α-helix displays two negative peaks at around 208
nm and 222 nm, the β-sheet shows one negative peak at around 218 nm, and the random
coil has a single negative peak at approximately 198 nm. We collected CD spectra of
OmpA and OmpT in the presence and absence of Ficoll 70. BSA was utilized as a
control for the non-specific interference. Since Ficoll 70 is a well-established inert cosolute used in studies of many proteins, it should not affect the structure of a wellfolded stable protein such as BSA. As shown in Figure 2.6A, the spectrum of BSA
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collected in the presence or absence of Ficoll 70 overlaid well with each other,
indicating that Ficoll 70, even at a concentration as high as 20%, had little non-specific
effect on the far UV CD spectrum. Therefore, any changes of the spectra of OMPs
collected in the presence of Ficoll 70 would be a result of the structural changes of the
proteins due to the Ficoll. As the CD spectra revealed (Figure 2.6B and C), the presence
of the crowding agent caused a decreased in the peak intensities and a red shift of the
peak positions for both OMPs. An effort to deconvolute the spectra quantitatively into
specific secondary structure compositions was not successful. This is not surprising
since the reference data sets used to develop the deconvolute software are mostly the
spectra of folded water soluble proteins rather than membrane proteins. However, a
similar change in the spectra of OmpA and OmpT suggested a similar effect of Ficoll
70 on the protein secondary structure.
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Figure 2.6 Far UV CD spectra of BSA (A), unfolded OmpA (B) and OmpT (C) in the
absence (open) and the presence (filled) of Ficoll 70.

2.3.4 Crowding had little influence on tertiary structure of OMPs monitored using
intrinsic fluorescence
The fluorescence spectra of OmpA and OmpT were collected in the presence and
absence of Ficoll 70.

A structural change would cause a change of the

microenvironment of the aromatic residuals in a protein, including tryptophan, tyrosine
and phenylalanine, which would in turn affect their fluorescence emission. Specifically,
a blue shift of the peak position and an increase of the emission intensity usually
indicate that the aromatic residues have moved into a more hydrophobic environment
while a red shift of the peak position and a decrease of its intensity indicate that the
residues have moved into a more hydrophilic environment. First we used BSA as a
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control sample to determine if the presence of 30% Ficoll 70 had any effect on the
fluorescence emission of the protein. We found the Ficoll 70 decreased the intensity
of fluorescence emission by about 70%, indicating that it affected the fluorescence
signal non-specifically. Since the fluorescence intensity was very sensitive to the
solution environment, the presence of Ficoll 70 quenched the fluorescence emission of
BSA. However, non-specific interference should not change the wavelength of the
emission, while it could have a significant influence on its intensity. As shown in
Figure 2.7A, after normalizing each spectrum to its own maximum intensity, the
normalized spectra of BSA obtained in the absence or presence of Ficoll 70 overlapped
well. Next, we collected fluorescence emission spectra of two OMPs, normalized the
spectra, and examined whether the presence of Ficoll 70 affected the emission
wavelength. We found that the OmpA (Figure 2.7B) spectrum did not have a shift,
while OmpT spectrum (Figure 2.7C) had a slight red shift, indicating either there was
no structural change, or the change did not generate net effect on the fluorescence signal
of both OMPs.
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Figure 2.7 Fluorescence emission spectra of BSA (A), unfolded OmpA (B) and OmpT
(C) in the absence (open) and the presence (filled) of Ficoll 70.

2.3.5 Unfolded OmpA assumed a more compact structure under the crowded condition
as revealed by limited protease digestion experiment
Limited protease digestion is another technique that has been used to investigate protein
structures, especially in the unfolded state. Trypsin and chymotrypsin recognize
specific sequences. When such recognition sites are exposed at the surface of a protein
or in a flexible region of the protein, they are more accessible to digestion. Therefore,
by monitoring the rate and efficiency of digestion, we can obtain information about
protein structure and structural changes.
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We chose two proteases, trypsin and chymotrypsin, in this experiment. Trypsin
recognizes lysine and arginine, while chymotrypsin digests peptide bonds after
aromatic and large aliphatic amino acids. Before we could use these enzymes to
characterize the structures of OMPs, we first needed to determine if the activities of the
enzymes themselves were affected by the presence of Ficoll 70. To determine the
intrinsic activity of the enzymes in the presence and absence of the crowding agent, we
used small synthetic substrates as described in the Materials and Methods section.
Experimental data was fitted using Michaelis-Menton kinetics equation:

v

Vmax  [ s]
K m  [ s]

where v represents the reaction rate at a certain concentration of the substrate [s]. Vmax
represents the maximum rate achieved by the system when saturated with substrate.
The Michaelis constant, Km, is the substrate concentration at which the reaction rate is
half of the maximum rate.

The reaction rates for each protease for its specific small substrate were recorded at
different substrate concentration and fitted using the Michaelis-Menton equation
(Figure 2.8). The fitting results (Table 2.3) showed that the presence of 20% Ficoll 70
had a very small effect on the Km and Vmax of the proteases, when we considered the
large errors. We found that the enzymatic activities of both proteases toward small
substrates were not significantly influenced by the crowding condition, which is
consistent with an earlier study that reported that the activity of trypsin was not affected
by the presence of the crowding condition 101.
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Table 2.3 Parameters of trypsin and chymotrypsin activities measured with small
substrates in the absence and presence of 20% Ficoll 70.
Trypsin

Chymotrypsin

Vmax (AU/mg)

Km (mM)

Vmax (AU/mg)

Km (mM)

No Ficoll 70

87.7±10.9

0.02±0.004

1.5±0.03

0.5±0.15

20% Ficoll 70

104.8±7.9

0.03±0.008

2.1±0.12

0.4±0.07

Figure 2.8. Plots of trypsin (A) and chymotrypsin (B) digestion rate in the absence
(open) and the presence (filled) of 20% Ficoll 70 versus the concentration of small
molecule substrates fitted by Michaelis-Menton equation.
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Next, we used BSA as a control for Ficoll 70 effect on the activity of the protease when
the substrate is a large globular protein (Figure 2.9A). We found that digestion reaction
of trypsin and chymotrypsin was faster in 20% Ficoll solution than in the absence of
Ficoll. The increased reaction activity could be a result of the increased binding
strength between the protease and BSA, due to the exclusive volume effect during
crowding. The presence of 20% Ficoll had a similar effect on the trypsin digestion of
OMPs as with BSA (Figure 2.9 left). However, when chymotrypsin was used in the
digestion, OmpA was more resistant to digestion, while OmpT was similar to BSA
(Figure 2.9 right). The different results between the trypsin and chymotrypsin digestion
could be explained by the difference in digestion specificity of the two enzymes.
Chymotrypsin preferentially cleaves amide bonds on the carboxyl side, which is an
aromatic and large aliphatic residual. Therefore, OmpA underwent a structural change
under the crowding condition, in which hydrophobic residues formed a more compact
and well protected core. On the other hand, trypsin digests the amide bond after Lys
and Arg, which are likely located at solvent exposed surfaces, even in a well-folded
protein. Thus, although Ficoll 70 induced OmpA to fold into more a compact structure,
the Lys and Arg were still exposed.

44

Figure 2.9 Trypsin and chymotrypsin digestion pattern of BSA (A), OmpA (B) and
OmpT (C) in pure buffer solution (open) and in 20% Ficoll 70 (filled).
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2.3.6 Effect of the crowding condition on the rate of membrane insertion of the
transmembrane domain of OmpA
Comparing the crystal structures of the two proteins, we noticed that OmpA contains a
large C-terminal periplasmic domain, while OmpT has a single transmembrane
domain.88, 89 To investigate if the different behaviors of the two proteins in the presence
of Ficoll 70 were due to the periplasmic domain, we constructed a plasmid encoding
the sequence of the transmembrane domain of native OmpA (OmpA171).

The

transmembrane domain of OmpA folds into an eight-stranded β-barrel, and its structure
has been determined by both X-ray crystallography and NMR.102-104

If it is

reconstituted into proteoliposomes, the transmembrane fragment of OmpA forms ion
conducting channels.100 We purified the unfolded OmpA171 and conducted a refolding
experiment under the similar condition to the full length OmpA. The folded and
unfolded OmpA171 were separated on the SDS polyacrylamide gel, in which the
unfolded species moved faster than the folded one (Figure 2.10A and 2.10B).105 In the
absence of Ficoll 70, the folding and membrane insertion rate of OmpA171 was 0.014
± 0.002 min-1 and the rate increased approximately twice upon the addition of 20%
Ficoll 70 (0.028 ±0.002 min-1), indicating that the addition of Ficoll 70 accelerated the
folding and insertion process of OmpA171 (Table 2.2). We also observed that
OmpA171 tended to aggregate. High molecular weight bands corresponding to
different aggregation states emerged during extended incubation (Figure 2.10D). The
presence of Ficoll 70 slightly increased the efficiency of the OmpA171 refolding
(Figure 2.10C).
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Figure 2.10 OmpA171 refolding and membrane insertion. A. In the absence of Ficoll
70. B. In the presence of 20% Ficoll 70. BS, boiled sample. M, protein molecular
weight marker. Numbers represent different incubation time in min. C. Kinetics of
OmpA171 refolding in the absence (open) or presence (filled) of 20% Ficoll 70. Data
were averages of three independent experiments and fitted to a single exponential
equation. D. OmpA171 aggregated over time during the refolding process. Higher
molecular weight bands are clearly visible in the refolded OmpA171 sample, but not
in the refolded OmpA sample. Positions of folded and unfolded proteins are marked.

2.4 Discussion
We used Ficoll 70 as a model crowding agent and studied the crowding effect on the
folding and membrane insertion of OmpA and OmpT. First, we found that the folding
and membrane insertion rate of OmpA decreased by eight-fold in the presence of 20%
Ficoll 70, while the rate of OmpT folding was barely affected. In addition, we noticed
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that OmpT folded significantly faster than OmpA under the current experimental
condition (Table 2.2). To investigate the mechanism underlying the difference, we
examined the structures of the water-soluble intermediates of both proteins. The results
indicated that OmpA possessed a more compact structure under crowded condition,
while the residual structure of OmpT was barely affected. Finally, we examined
whether the presence of the periplasmic domain slowed the membrane insertion of
OmpA, we created a truncated OmpA construct containing only the transmembrane
domain and investigated its rate of folding and the corresponding effect of crowding.
Interestingly, while OmpA171 and full length OmpA had similar folding rates in the
dilute buffer solution, the full length OmpA refolded much slower than OmpA171 in
the presence of 20% Ficoll 70. The periplasmic domain in the full length OmpA slowed
down its folding and membrane insertion under the crowding condition. In addition,
we found that the unfolded OmpA171 was less stable than full length OmpA during
the refolding. It aggregated and formed oligomeric species of high molecular weight
over time. The periplasmic domain of OmpA apparently played a role in stabilizing
the structure of OmpA in the unfolded state, prior to its folding and insertion into the
OM. Our results are consistent with the conclusion of an earlier study, in which
Fleming and coworkers suggested that the periplasmic domain of OmpA serves as a
“chaperone” during its folding to keep the protein stable and soluble in the periplasm.106

2.5 Conclusions
OMPs play important roles in controlling the membrane permeability for nutrients and
toxins. Most studies on the folding mechanism of OMPs were conducted in a dilute
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buffer solution. However, the actual folding environment for OMPs is the periplasm,
which is a molecularly crowded condition. In this study, we used Ficoll 70 as a model
crowding agent and studied the crowding effect on the folding and membrane insertion
of OmpA and OmpT. We found that under the crowding condition, refolding and
insertion of the transmembrane domain of OmpA was slowed down by the presence of
its periplasmic domain in exchange for an improved folding efficiency. This function
of the periplasmic domain of OmpA is hardly noticeable in the dilute buffer solution.
Macromolecular crowding has long been known to significantly affect the protein
folding process. Studying protein folding under the crowding condition will add new
our understanding of the protein folding in the living cell.

Copyright © Cui Ye 2014
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CHAPTER III. UNFOLDING STUDY OF A TRIMERIC MEMBRANE
PROTEIN ACRB
Part of this chapter are taken from “Unfolding study of a trimeric membrane protein
AcrB”, 2014, Protein Sci. DOI: 10.1002/pro.2471

3.1 Introduction
After their translation, proteins need to fold into and maintain a three-dimensional
structure to function. The folding process and thermodynamic stability of proteins have
been actively pursued areas of study due to their importance in virtually all life
processes.

The thermodynamic stability measurement of the integral membrane

protein remains to be a challenging task and study on the mechanism of their folding is
scant.74, 107-109 To quantitatively determine the thermodynamic stability of a protein, its
reversible unfolding and refolding has to be achieved.74, 110, 111 The first α-helical
membrane protein that has been successfully refolded from an SDS denatured state is
bacteriorhodopsin.112, 113 Since then, refolding of a few additional α-helical membrane
proteins has been reported, including diacylglycerol kinase114, a potassium channel
KcsA115, and the lactose permease LacY116.

Refolding is challenging for helical membrane proteins. The approach taken to unfold
a protein is crucial for its refolding efficiency. Methods suitable for soluble proteins
such as thermal and acid/base denaturation usually lead to irreversible precipitation or
aggregation of α-helical membrane proteins due to their large hydrophobic core.74, 117
So far, chemical unfolding using urea, SDS and less commonly trifluoroethanol (TFE)
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are the only viable approaches demonstrated to enable successful refolding of α-helical
membrane proteins.118-120 Urea exerts its effect directly, by binding to the protein, or
indirectly, by altering the solvent environment, both resulting in the solvation of the
hydrophobic core of the protein,121 while the mechanism of denaturation by SDS
remains a topic of debate.111, 122, 123 The far UV CD analysis suggests that membrane
proteins denatured by SDS tend to maintain a high level of helical structure.124, 125 This
state is arguably a better representative of the unfolded state of helical membrane
proteins.110, 126 An experimental readout that is sensitive to the conformational change
of protein during unfolding is another critical factor of the stability measurement.
Methods that are extensively used include the far UV CD spectrum which is sensitive
to the secondary structure, and the intrinsic fluorescence spectrum that reveals the
overall conformational change of a protein.124, 125, 127

In this study, we investigated the unfolding and potential of refolding of an E. coli IM
protein AcrB. Although many attempts have been made to study the folding of αhelical membrane proteins, these folding studies focus on membrane proteins with
relatively simple structures, such as the small multidrug resistance transporter EmrE128,
the human peripheral myelin protein 22129, the ATP-binding cassette transporter
BtuCD130 and the sugar transport protein GalP131 and LacY116, 132, are all helix bundles
composed of a small handful of transmembrane helices.

Reports on folding of

multimeric and multidomain helical membrane proteins are lacking. E. coli AcrB is an
IM trimeric transporter, in which each monomer contains both a transmembrane
domain and a large periplasmic domain formed by two long loops between
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transmembrane helices 1 and 2, and helices 7 and 8.32, 55 The structure of trimeric AcrB
is shown in Figure 3.1.51 Thermal unfolding monitored by CD spectroscopy at 222 nm
was measured in a previous study.133 The protein retained a high helical content even
when the temperature was increased to 98 °C. In addition, a clear transition point was
lacking.

In this study, we examined AcrB unfolding induced by two chemical

denaturants, urea and SDS. Intrinsic fluorescence emission and CD signals of the
protein were monitored to follow the unfolding and refolding processes. While AcrB
failed to refold reversibly under the experimental conditions tested in this study, its
monomeric mutant, AcrBΔloop, could be refolded. In addition, the unfolding curve
could be fitted by a two-state unfolding model, indicating a lack of folding intermediate
states.

Figure 3.1 Structure of AcrB (created from 2GIF.pdb51 using Pymol18). Top view (left)
and side view (right, with the subunit at the back removed for clarity) of an AcrB trimer.
Positions of domains as discussed in the text are labeled in the side view. The two lines
indicate the position of the cell membrane.
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3.2 Materials and Methods
3.2.1 Plasmid construction, protein expression and purification
Plasmid pQE70-AcrB, pQE70-AcrBΔloop and pQE70-AcrBV225C/A777C were constructed
for an earlier study.133, 134 Plasmid encoding the triple mutant AcrBW13F/W515F/W895F was
constructed using the QuikChange Site Directed Mutagenesis Kit (Agilent
Technologies) with pQE70-AcrB as the template. Protein was expressed and purified
following a published protocol with slight modifications.135

Cells were cultured at

37 °C in Lysogeny Broth media containing 100 g·mL-1 ampicillin overnight. The
protein expression was conducted under basal condition without induction. Cell was
collected by centrifugation at 7,000 g for 15 min at 4 °C and used immediately for
purification.

The cell pellets were suspended in a lysis buffer (0.5 mM PMSF, 20 mM Na-phosphate,
0.3 M NaCl, pH 7.9) and sonicated for 25 min in water/ice bath with 5 s on/off intervals.
The cell lysate was centrifuged at 15,317×g and 4°C for 20 min. The pellet was then
resuspended in a buffer containing 0.5% (w/v) Triton X-100, 20 mM Na-phosphate,
0.3 M NaCl, pH 7.9. The mixture was then incubated at 4°C with rotating for 2 hours,
followed by centrifugation at 15,317×g and 4°C for 20 min.

The supernatant,

containing the AcrB dissolved in detergent, was collected and mixed with Ni-NTA
Sepharose resin (Qiagen Inc., Valencia, CA) after the addition of imidazole to a final
concentration of 10 mM to reduce non-specific binding to the resin during purification.
The binding was allowed to proceed by rotating at 4°C for 40 min. The suspension
was packed into an empty 5 mL column and washed with a wash buffer (50 mM
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imidazole, 0.03% n-Dodecyl β-D-maltoside (DDM), 20 mM Na-phosphate, 0.3 M
NaCl, pH 7.9). The target protein was eluted using a buffer contained 0.5 M imidazole,
0.03% DDM, 20 mM Na-phosphate, 0.3 M NaCl, pH 7.9. Protein samples were
dialyzed overnight in the same buffer in the absence of imidazole at 4°C overnight. The
same buffer was used throughout this study unless otherwise noted. The protein
concentration was determined using Pierce BCA Protein Assay Kit (Thermal Scientific,
TX).

Protein activity was evaluated by measuring the minimum inhibitory concentration
(MIC) of BW25113ΔacrB containing plasmid encoding this protein as described.136
BW25113ΔacrB containing plasmid pQE70-AcrB and the empty vector pQE70 were
used as positive and negative controls, respectively.

3.2.2 Unfolding of trimeric AcrB
Protein unfolding was initiated by titrating concentrated urea (8.0 M) or SDS (0.2% or
2%, w/v) into freshly purified AcrB in the dialysis buffer. A fluorescence emission
spectrum between 300 to 400 nm was recorded at each titration point with a LS-55
fluorescence spectrometer (PerkinElmer, Inc., Waltham, MA) with excitation
wavelength of 280 nm. The maximum fluorescence intensity of each spectrum was
converted into fraction of protein folded using Equation 3.1 and plotted as a function
of urea molar concentration or SDS/DDM molar ratio. A titration plot of L-tryptophan
with SDS solution as a control was determined similarly.
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𝑦=

𝑌−𝑌𝑚𝑎𝑥
𝑌𝑚𝑎𝑥 −𝑌𝑚𝑖𝑛

Eq. 3.1

in which, Y denotes the fluorescence intensity, and Ymax and Ymin are the maximum and
minimum values, respectively.

To reduce the disulfide bonds in AcrBV225C/A777C, purified protein was divided into two
aliquots: one incubated in solution buffer containing 0.5 mM dithiothreitol (DTT) at
25 °C for 2 hours to reduce disulfide bonds, the other incubated in the absence of DTT
under the same conditions. Wild type AcrB was treated similarly and used as the control.
Plots of fraction of folded protein versus SDS/DDM molar ratio were obtained as
described above.

3.2.3 BN- PAGE analysis and far UV CD spectroscopy
Purified AcrBWT and AcrBDloop were incubated in a buffer solution in the absence or
presence of SDS at a mole ratio of 2.4 at 25 °C for 20 min and then Blue Native
polyacrylamide gel electrophoresis (BN-PAGE) was performed as described in a
published protocol.137, 138 Briefly, blue native loading buffer was added into protein
sample to give a final concentrations of 0.1 M 6-aminoocaproic acid, 1% Coomassie
Brilliant Blue G-250, 1% glycerol. Protein samples were loaded on to a 4-20% gradient
polyacrylamide gel (Bio-Rad, Hercules, CA). Electrophoresis was performed using a
cathode running buffer containing 50 mM Tricine, 7.5 mM imidazole 0.02%
Coomassie Brilliant Blue G-250, pH 7.0 and a anode running buffer (25 mM imidazole,
pH adjusted with HCl to 7.0) at 4°C, at 15 mA for 2 h. The protein bands were
visualized with Coomassie blue stain.
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Purified AcrB after dialyzed overnight as described above was titrated with 0.2% (w/v)
SDS solution at 25 °C. CD spectra in the range of 190 nm and 250 nm were collected
with a JASCO J-810 spectrometer. The ratio of the mean residue ellipticities at 222 nm
and 208 nm was converted into fraction of folded protein using Equation 3.1 and plotted
as a function of DDM/SDS molar ratio.

3.2.4 Refolding of AcrB
To refold protein denatured by urea, purified AcrB was first incubated in the dialysis
buffer containing 4 M urea at 25 °C for 20 min to fully unfold the protein, followed by
titration with the urea-free buffer. To refold SDS denatured protein, the buffer solution
containing 10% DDM was titrated into the unfolded protein sample containing SDS at
the SDS/DDM molar ratio of 11.8. Fluorescence emission spectra and CD spectra were
recorded and analyzed to obtain the refolding curve as described above.

3.3 Results
3.3.1 Chemical denaturation of trimeric AcrB monitored by intrinsic fluorescence
A reversible unfolding/refolding process is a prerequisite for obtaining thermodynamic
parameters of protein stability.74 Urea and SDS have been used successfully in the
refolding of membrane proteins.109, 110 To study the stability of AcrB, we examined its
unfolding in these two denaturants and monitored the decrease of intrinsic fluorescence
intensity during unfolding.

Protein unfolding usually leads to the transition of

fluorescent residues to shift from the protected hydrophobic core to a solvent exposed
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hydrophilic environment, resulting in a decrease of fluorescence signal and sometimes
a red shift of the emission peak.

When AcrB unfolded in urea, a dramatic decrease of tryptophan fluorescence intensity
was observed (Figure 3.2A). Therefore, we chose to monitor the decrease of the
maximum fluorescence emission as an indicator of protein unfolding. The titration
curve with urea (Figure 3.2B) displayed a sigmoid profile with a transition point at
around 3.0 M. The unfolding of protein with urea reached the end point when urea
concentration was 5.0 M.
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Figure 3.2 Chemical denaturation of AcrB monitored using the intrinsic fluorescence.
A. Spectra of AcrB in the absence (solid line) and the presence of (dashed line) of 6 M
urea. B. Unfolding of AcrB induced by urea titration. C. Spectra of AcrB in the absence
(solid line) and the presence of SDS (dashed line, SDS/DDM molar ratio 2.4). D.
Unfolding of AcrB induced by the titration of SDS (black squares). L-tryptophan (open
squares) was used as a control to confirm the lack of non-specific effect of SDS on
fluorescence emission. Each experiment was repeated at least three times, and the
average values and standard deviations are shown.

A significant decrease of the fluorescence signal was also observed when we performed
a similar titration using SDS (Figure 3.2C).

The transition point occurred at a

SDS/DDM molar ratio of around 1.0 (Figure 3.2D). A small fluorescent amino acid L-
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tryptophan was titrated similarly with SDS to serve as a control of potential nonspecific fluorescence change. As revealed in Figure 3.2D, the presence of SDS had
little effect on the fluorescence of L-tryptophan, indicating that the change of buffer
condition upon the addition of SDS did not have a non-specific effect on the
fluorescence emission. Therefore, the decrease in AcrB fluorescence emission during
the titration process was caused by protein structure change. Titration results revealed
that the protein reached the unfolding end point in SDS when SDS/DDM molar ratio
reached 2.4.

3.3.2 Contribution of signal change from trimer dissociation
Dissociation of AcrB trimer in the presence of SDS was confirmed using BN-PAGE.
Only one trimer band was observed when a fresh AcrB sample was analyzed using BNPAGE (Figure 3.3, lane 1). In the presence of SDS at a molar ratio of 2.4, the trimer
band was completely converted into a monomer band, indicating that all AcrB trimers
dissociated into monomers (Figure 3.3, lane 2). To confirm that the observed change
of migration was not due to the nonspecific association of SDS, we conducted a control
experiment using a monomeric AcrB mutant created in a previous study, AcrBΔloop.134
In AcrBΔloop, the long loop that is critical for the AcrB trimerization is truncated, which
leads to the trimer dissociation. However, the overall secondary and tertiary structures
of the mutant were comparable to that of the wild type AcrB.134 As shown in Figure
3.3, lanes 3 and 4, the addition of SDS did not shift the migration of AcrBΔloop in the
gel, indicating the observed change in lane 2 was due to trimer dissociation.
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Figure 3.3 AcrB trimer dissociation observed in BN-PAGE gel. A. Representative BNPAGE gel image of wild type AcrB samples without (lane 1) or with (lane 2) incubation
with SDS (SDS/DDM molar ratio 2.4). AcrBΔloop samples were treated similarly and
used as controls (lane 3 and 4). Positions of monomer (M) and trimer (T) for both gel
as well as molecular weight markers were labeled.

To examine the relative contributions of trimer dissociation and monomer unfolding to
the observed change of fluorescence, we monitored the unfolding of a mutant,
AcrBV225C/A777C.

AcrBV225C/A777C contains inter-subunit disulfide bonds between

neighboring subunits, and exists as a covalently linked trimer.139 Formation of the
disulfide bond between V225C and A777C of adjacent monomers was complete as
revealed by the lack of monomer band when the protein was analyzed on non-reducing
SDS-PAGE gel.138 These inter-molecular disulfide bonds have no effect on AcrB
activity, indicating little negative impact on protein structure.139 We compared the SDS
titration curves of AcrBV225C/A777C with wild type AcrB (Figure 3.4B), and their titration
curves under a reducing condition with a non-reducing condition (Figure 3.4C and
3.4D). Incubation in the presence of 0.5 mM of DTT at room temperature for two hours
completely reduced disulfide bonds in AcrBV225C/A777C trimer (Figure 3.4A). The trimer
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band was completely converted into a monomer band. Wild type AcrB does not contain
any intrinsic disulfide bonds. According to Figure 3.4C, the overlapped titration curves
of wild type AcrB in the absence and the presence of DTT confirmed that DTT had
little influence on protein structure except for reducing disulfide bonds. The loss of
disulfide bonds in AcrBV225C/A777C trimer had little effect on protein stability (Figure
3.4D). Therefore AcrB monomer unfolding was the primary cause of the observed
sharp decrease in the intrinsic fluorescence intensity.
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Figure 3.4 SDS-induced unfolding of wild type AcrB and AcrBΔloop. A. Representative
SDS-PAGE gel image of AcrBV225C-A777C before (-) or after (+) the reduction of DTT
(0.5 mM). Positions of monomer (M) and trimer (T) are labeled. B. SDS titration of
wild type AcrB (black squares) and AcrBV225C/A777C (grey triangles). C. SDS titration
of wild type AcrB before (black squares) or after (open squares) reduction with DTT.
D. SDS titration of AcrBV225C/A777C before (grey triangles) or after (open triangles)
reduction with DTT. Each experiment was repeated at least three times and the average
values and standard deviations are shown.

3.3.3 Unfolding of a triple AcrB mutant
As discussed above, the intrinsic fluorescence of a protein can reflect its conformational
state. Trp residues are the major contributor to protein intrinsic fluorescence. There
are nine Trp residues in the sequence of AcrB, three in the transmembrane domain
(W13, W515, and W895) and six in the periplasmic domain (W187, W634, W754,
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W789, W809, and W859). We chose to mutate all three Trp in the transmembrane
domain to Phe to investigate the effect on the observed unfolding profile. To confirm
that the mutations did not drastically alter AcrB structure, we determined the transport
activity of the mutant by measuring the MIC of an AcrB knockout strain
BW25113ΔacrB harboring a plasmid encoding AcrBW13F/W515F/W895F (pQE70AcrBW13F/W515F/W895F). The same strain harboring the empty vector (pQE70) or plasmid
encoded wild type AcrB (pQE70-AcrB) was used as the negative and positive control,
respectively. Two well-established AcrB substrates were tested, erythromycin and
novobiocin. For erythromycin, the MIC of the strains containing wild type, mutant, or
no AcrB was 160 µg/mL, 160 µg/mL, and 5 µg/mL, respectively. For novobiocin, the
MIC of the three strains was 80 µg/mL, 40 µg/mL, and 10 µg/mL, respectively. For
the two substrates tested, the mutant retained complete or partial activity, indicating
that the overall structure of the protein was largely intact. The replacement of three
Trp with Phe residues led to a decrease of the fluorescence intensity by approximately
30%, and the peak of the emission spectrum shifted to a slightly longer wavelength
(Figure 3.5A). Next, SDS induced unfolding was measured (Figure 3.5B). The
unfolding profile of the triple mutant was very similar to the profile of wild type AcrB.
Removal of three Trp from the transmembrane domain did not lead to an observable
shift of the unfolding profile, indicating that the observed signal change was actually
largely contributed by Trp residues from the periplasmic domain.
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Figure 3.5 SDS-induced AcrBW13F/W515F/W895F unfolding.

A. A comparison of

fluorescence spectra of wild type AcrB (solid line) and mutant AcrBW13F/W515F/W895F
(dashed line).

The spectra were normalized to observe the peak shift. Original

concentration adjusted spectra were shown as an inset.

B. Unfolding of

AcrBW13F/W515F/W895F induced by the titration of SDS (open squares). Unfolding of wild
type AcrB was also shown as a control (grey squares). Each experiment was repeated
at least three times, and the average values and standard deviations were shown.

3.3.4 Chemical denaturation of trimeric AcrB monitored by CD spectroscopy
To further examine the structural change of AcrB in the presence of SDS, far UV CD
spectra were collected for an AcrB sample in the absence and presence of SDS at a
SDS/DDM molar ratio of 2.4. Changes in both intensity and wavelength of the
spectrum peak were observed in the CD spectra, revealing an alteration of the
secondary structure composition and arrangement (Figure 3.6A). Effort to deconvolute
the CD spectra into individual secondary components using online software provided
by the DICHROWEB140 server was not successful, likely due to the lack of an
appropriate reference set for membrane proteins. A SDS titration monitored by CD
was performed to examine the disruption of secondary structure components during
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protein unfolding. The ratio of mean residue ellipticity at 222 nm and 208 nm was used
to reflect the secondary structure change (Figure 3.6B). Similar to the results with
intrinsic fluorescence, structural change was complete at a SDS/DDM molar ratio of
2.4.

Figure 3.6 SDS-induced denaturation of AcrB monitored by CD. A. Spectra of purified
AcrB in the absence (solid line) and the presence (dashed line, SDS/DDM molar ratio
2.4) of SDS. B. AcrB titration with SDS monitored by the ratio of ellipticities at 208
nm and 222 nm. C. Comparison of unfolding profiles. Comparison of the process of
unfolding monitored by CD (grey squares) and fluorescence intensity (black square).
The curves showed the fitting of the CD and fluorescence intensity data using a simple
two-states unfolding model. Each experiment was repeated at least three times and the
average value and standard deviation were shown.

3.3.5 Comparison of AcrB unfolding plots monitored using fluorescence and CD
spectroscopy
While both unfolding plots revealed that the structure change (unfolding) was complete
at a SDS/DDM molar ratio of 2.4, the transition points were significantly different
(Figure 3.6C).

Furthermore, both plots could be fitted with a sigmoidal curve
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describing a simple two-state unfolding model from a folded state directly to an
unfolded state (Figure 3.6C). The transition point of wild type AcrB unfolding was
calculated to be 0.94±0.03 and 1.32±0.09 SDS/DDM molar ratio for CD and
fluorescence emission, respectively. Comparison between the plots suggested that the
rearrangement of protein secondary structure occurred prior to the global unfolding of
the tertiary structure.

3.3.6 Refolding of chemically denatured AcrB
To quantitatively determine the thermodynamic parameters of AcrB, reversible
refolding needs to be achieved. We first unfolded AcrB in the presence of 4 M urea,
and then diluted the sample to reduce the concentration of urea. As shown in Figure
3.7A and 3.7B, the fluorescence intensity began to increase when the concentration of
urea was reduced to below 2 M, and 57% of the fluorescence was recovered when the
urea concentration was reduced to 1 M. The presence of two separated unfolding and
refolding curves and the low recovery of spectral parameters indicated that AcrB did
not refold reversibly from the urea-denatured state under our experimental conditions.
We also collected the CD spectra of AcrB unfolded in urea (dotted line), and then after
dialyzed overnight (grey line) (Figure 3.7C). The secondary structure of the protein
was not regained.
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Figure 3.7 Refolding of AcrB. A. Unfolding (black) and refolding (grey) profiles of
AcrB in urea. B. Fluorescence emission spectra of AcrB in the native state (black line),
unfolded (dashed line, in 6.0 M urea), and after refolding (gray line). C. CD spectra of
AcrB in the native state (black line), unfolded state (dashed line, in 6.0 M urea), and
after refolding (gray line) in urea. D. Unfolding (black) and refolding (grey) profiles of
AcrB in SDS. E. Fluorescence emission spectra of AcrB in the native state (black line),
unfolded (dashed line, SDS/DDM molar ratio 2.4), and after refolding (gray line). F.
CD spectra of AcrB in the native state (black line), unfolded state (dashed line,
SDS/DDM molar ratio 2.4), and after refolding (gray line) in SDS.

To refold the SDS-denatured AcrB, we reduced the molar ratio of SDS in SDS/DDM
mixed micelles by adding aliquots of concentrated DDM solution. As shown in Figure
3.7D and 3.7E, the refolding curve did not overlap with the unfolding curve, with
around 25% fluorescence recovery at the lowest SDS/DDM molar ratio tested (0.07).
The CD spectrum of refolded sample was collected and compared with the spectra of
native and unfolded AcrB samples (Figure 3.7F). Again, the secondary structure of the
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protein was not fully recovered in the refolding sample. It was clear that the structure
of the protein was different from the native-like conformation. We have attempted to
refold the protein under a variety of different conditions, including varying the pH,
lipid vesicle concentration, and detergent concentration. None of these conditions led
to the successful refolding of the protein to the original conformation (data not shown).

Next, we experimented with the refolding of an AcrB mutant, AcrBΔloop. As mentioned
earlier, AcrBΔloop exists as a monomer, but has similar secondary and tertiary structure
as a monomeric subunit in a wild type trimer.134 Since the complete refolding of wild
type AcrB involves trimer association, we speculate that the refolding of a monomeric
AcrB mutant might be easier to achieve. Unlike the SDS induced unfolding of the wild
type protein, the unfolding of AcrBΔloop was not as cooperative (Figure 3.8A). However,
the unfolding was partially reversible when the SDS/DDM molar ratio was reduced
upon the addition of DDM. The CD spectrum of the refolded sample superimposed
well with that of the original folded protein, however the fluorescence spectrum was
not fully restored (Figure 3.8B and 3.8C).
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Figure 3.8 Refolding of AcrBΔloop. A. SDS induced unfolding (black diamonds) and
refolding (grey diamond) profiles of AcrBΔloop. B. Fluorescence emission spectra of
AcrBΔloop in the native state (black line), unfolded (dashed line), and after refolding
(grey line). C. CD spectra of AcrBΔloop in the native state (black line), unfolded state
(dashed line), and after refolding (grey line).

3.4 Discussion
In this study, we monitored the chemical denaturation of trimeric AcrB in the presence
of urea and SDS. Both trimer dissociation and monomer unfolding could potentially
lead to a change in the intrinsic fluorescence emission. However, we found that the
presence of inter-subunit disulfide bonds, which strengthened AcrB trimer stability by
covalently linking the three subunits, had little effect on the transition point of AcrB
unfolding monitored using fluorescence intensity. There are two potential reasons that
may lead to this observation. First, trimer dissociation could be spectroscopically silent.
Second, trimer dissociation could have occurred together with the global unfolding of
individual subunits. To further investigate the unfolding process, we monitored the
folding process using CD. The unfolding profiles monitored using CD was different
from that monitored using fluorescent intensity. Even though SDS cannot effectively
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unfold α-helices in the transmembrane domain, it causes a peak shift of the CD
spectrum and has been used as a probe of secondary structure change during α-helical
membrane protein unfolding.118, 119, 127 It is notable in our results that the initiation and
transition points of unfolding monitored using CD occurred at a significantly lower
SDS concentration than that monitored using fluorescence emission spectroscopy.
Therefore, the unfolding of AcrB trimer appeared to start with the structural
rearrangement of monomers, and possibly the concurrent dissociation of trimers. The
fluorescent intensity change indicates the disruption of the hydrophobic core and
exposure of aromatic residues. Based on our result, the change of fluorescence signal
was largely contributed by the unfolding of the soluble domain, which could be fitted
nicely with a two-state model. The unfolding of the transmembrane domain may not
generate

a

detectable

fluorescence

signal

change,

since

the

change

of

microenvironment for Trp residues in the transmembrane domain upon unfolding is not
likely as dramatic as Trp residues in the soluble domain.

We also attempted to refold the chemically denatured AcrB to quantitatively determine
the thermodynamic stability of folding for trimeric AcrB.

However, under our

experimental conditions, neither urea nor SDS denatured AcrB can be reversibly
refolded.

Interestingly, an AcrB monomeric mutant, AcrBΔloop, could regain its

secondary structure composition after SDS induced unfolding. The mutant was not
fully refolded into the native conformation as judged by the fluorescence spectrum.
The fine-tuning of the tertiary structure during AcrB in vitro refolding might require
trimerization. We speculate that trimerization, which is the last hurdle for the wild type
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AcrB to refold into a native-like structure, might be difficult to achieve in an artificial
refolding condition. The complete refolding of AcrB might require a condition more
closely mimicking the native cell membrane, in which multiple subunits are accessible
to each other and the transmembrane domain is stabilized in a lipid bilayer.

The unfolding process of AcrB trimer was clearly different from the observation of
unfolding of the tetrameric GlpF, which occurs via a stable dimeric intermediate
state.141 A larger oligomeric membrane protein, the heterotetrameric BtuCD has been
refolded in detergent micelles.130 The protein complex consists of two trans-membrane
protein subunits, BtuC, and two cytoplasmically located nucleotide-binding protein
subunits, BtuD. Results from the refolding study support the idea of cooperative
folding and assembly of the constituent protein subunits of the BtuCD transporter. This
is also consistent with the observed correlation between subunit unfolding and
dissociation during the unfolding of an AcrB trimer.

Different from AcrB, the

structural organization in BtuCD is modular. Therefore, there is a certain degree of
flexibility to allow independent folding of BtuC in detergent micelles and BtuD in
aqueous solution. In contrast, the sequence segments that fold into the transmembrane
domain and segments that fold into the periplasmic domain in AcrB are interdigitated.
Folding of these two domains is likely more tightly correlated and reliant on each other.
It has been widely accepted that the unfolded state of a transmembrane helix bundle
remains to be highly helical. In the case of AcrB, we speculate that the unfolded state
of the protein is consisted of a loosely packed transmembrane helix bundle tied to the
more disordered periplasmic loops.

The anchoring effect of the transmembrane
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component could actually be a facilitating factor during the refolding of the periplasmic
domain, which subsequently brings the transmembrane helices back to their native-like
positions.
3.5 Conclusion
Stability is an important parameter that is essential for investigations on protein
structures and functions, including crystallography, protein design and engineering,
folding and misfolding, and mechanism of disease-related mutations and aggregation.
Thermodynamic stability measurements of α-helical membrane proteins are rare and
are not frequently reported due to the difficulty in achieving reversible
unfolding/refolding. So far, quantitative stability measurement has only been achieved
for a handful of α-helical membrane proteins, most of which have simple structures
consisting of a transmembrane helix bundle.

In this work, we investigated the

unfolding and conditions of refolding of a multi-domain trimeric α-helical membrane
protein, E. coli inner membrane protein AcrB. Our results suggested that the unfolding
of AcrB started with a local structural rearrangement, probably coincidently with a
dissociation of the trimer, and were followed by the collapse of hydrophobic cores in
the solvent exposed periplasmic domain.

Refolding of trimeric AcrB was not

successful, while the refolding of secondary structure in individual monomers could be
achieved, suggesting that the re-association of the trimer might be the limiting factor
to obtain folded wild type AcrB in vitro. Investigation of refolding in a more nativelike lipid bilayer is required for more complete refolding and thus more insight in the
refolding.
Copyright © Cui Ye 2014
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CHAPTER IV. THE CORRELATION BETWEEN ACRB TRIMER
ASSOCIATION AFFINITY AND EFFLUX PUMP ACTIVITY
4.1 Introduction
The stabilities of water soluble proteins and protein oligomers are tuned to match their
biological

functions,

the

physiological

environment,

and

the

regulatory

mechanisms.142-147 Usually a protein is only marginally stable. This modest stability
is thought to be critical for protein function, which usually requires a certain degree of
structural flexibility involving conformational changes for function. Studies on the
stability-activity relationship lag behind in the area of membrane protein research.
Such studies have recently become possible due to the advances of techniques and
accumulation of knowledge of membrane protein structure and functions. In the past
two decades much insight has been obtained on energetics of membrane protein
oligomerization in detergent micelles and phospholipid bilayer.148 Yet, a systematic
study investigating the correlation between oligomer stability and in vivo activity of a
multi-span and multi-domain helical membrane protein is still missing. Here, we used
E. coli AcrB as a model protein to investigate the relationship between its trimer
stability and drug efflux activity.

AcrB is an obligate trimer that exists and functions exclusively in a trimeric form
(Figure 4.1A).149 AcrB conducts the inward flow of protons across the IM to drive
conformational changes that facilitate substrate efflux. The structure of AcrB was first
solved by x-ray crystallography in the asymmetric trimer form in 2006, which supports
a conformational cycling model for drug transport.51, 55 Up to date, more than thirty
73

structures of AcrB have been deposited into the Protein Data Bank. However, crystal
structures cannot provide insight into how its trimer affinity affects the drug efflux
activity.

Figure 4.1 Structure of AcrB. A. Top view and side view (with the subunit at the back
removed for clarity) of an AcrB trimer. Domains as discussed in the text are labeled for
the side view. B. Zoom in view of the protruding loop that is critical for the intersubunit interaction. Residues discussed in the text are highlighted using space-filled
models and labeled. C. Residues lining the interface between TH1 and TH8 are
highlighted by ball-and-stick models. L886, E893, and W895 are labeled.
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We previously created several AcrB mutants with modifications on the periplasmic
inter-subunit interface that displayed different levels of drug efflux activity. 133,

150

These sites of mutation are located on a protruding loop critical of each subunit for
trimerization (Figure 4.1B). A single amino acid substitution was shown to almost
completely dissociate the trimer structure (AcrBP223G). In this work, we introduced
additional mutations at three sites on the transmembrane inter-subunit interface,
including single, double, and triple replacements (Figure 4.1C), aiming at disrupting
trimer association without affecting the overall structure of individual monomers.
Structural characterization and stability measurement indicated that the mutations in
the protruding loop decreased the stability of individual monomers,151 while the effect
of the mutations in the transmembrane helix was minimal. Therefore, we used the latter
to determine their relative trimer affinities and biologically relevant transport activities.
When the efflux activity of the AcrB variants were plotted against their relative trimer
stabilities, a requirement of a threshold stability was observed.

4.2 Materials and Methods
4.2.1 Protein cloning, expression and purification
Plasmid pQE70-AcrB was created in a previous study by routine molecular cloning
methods.135 Mutations were introduced into the acrB gene in plasmid pQE70-AcrB
using the QuikChange Site-Directed Mutagenesis Kit according to the manufacturer’s
instructions (Agilent Technologies) and confirmed through DNA sequencing. Plasmid
containing acrB gene or its mutations was then transformed into E. coli BW25113
ΔacrB strain for protein expression. Expression level of each protein was determined
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using Western blot as described.152 Plasmids used in this study were constructed by
Dr. Wei Lu and Dr. Linliang Yu.

4.2.2 Structural characterization using CD and fluorescence spectroscopy
CD spectra and SDS induced unfolding monitored by fluorescence spectroscopy of
purified wild type AcrB and its mutants were collected as described in Materials and
Methods section of Chapter III.136 Titration data was fitted with a single exponential
equation to calculate the transition point of unfolding as described.118

4.2.3 Measurement of drug susceptibility, ethidium bromide accumulation and nile red
efflux
Drug susceptibility of each AcrB construct was determined by measuring the MIC of
BW25113ΔacrB containing plasmid encoding each protein as described.136 Ethidium
bromide (EtBr) accumulation and nile red efflux were performed following published
protocols.153, 154 The slope of a plot of fluorescence intensity versus time in second was
obtained as the accumulation or efflux rate in s-1. In all assays, BW25113ΔacrB
containing plasmid pQE70-AcrB or the empty vector pQE70 were used as positive and
negative controls, respectively.

MIC measurements of all AcrB mutants were

performed by Dr. Wei Lu and Dr. Linliang Yu.

To compare data from different measurements, MIC values for the four substrates and
EtBr accumulation rates were normalized against the positive control and converted
into the residual percent activities. For example, the MIC of erythromycin (Ery)
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obtained for the strain containing wild type AcrB (positive control) was 32-fold of the
MIC obtained for the strain without AcrB (negative control). If a mutant (for example,
AcrBL886G/E893G/W895G) has a MIC of 20 g/ml, which is 8-fold of the MIC of the
negative control, we would convert it into 25% residual activity. EtBr accumulation
rate was normalized similarly.

For instance, the EtBr accumulation rate of

BW25113ΔacrB was reduced by 15.7-fold of that of wild type AcrB.

If the

accumulation rate of BW25113ΔacrB was reduced by 1.6-fold after the expression of
an AcrB mutant (AcrBL886G/E893G/W895G, for instance), then the residual activity would
be calculated by dividing 1.6 by 15.7 to get 10.7%.

4.2.4 Method to calculate apparent trimer affinity of AcrB in detergent micelles
To determine the relative stability of AcrB mutants, protein was expressed and purified
as described in Materials and Methods section of Chapter III.133, 135, 136 Freshly purified
samples were analyzed using BN-PAGE as described.136 Software ImageJ was used to
quantify the trimer and monomer bands, which were used to calculate the percentages
of monomer and trimer in the sample.155 Concentration of AcrB was determined using
Pierce BCA Protein Assay Kit (Thermal Scientific INC., TX).

4.3 Results
4.3.1 AcrB variants with mutations at the inter-subunit interface
Since the goal of this study is to investigate how a change of trimer affinity would
affect AcrB efflux activity, we introduced mutations to disrupt protein-protein
interactions. To identify sites for mutation, we analyzed the inter-subunit interface
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using the online server ProtorP156 and the AcrB crystal structure 2DHH55. When two
AcrB subunits associate, ~12% of the overall decrease in accessible surface area (ASA)
is contributed by interactions between transmembrane helices (TH) (Figure 4.1C), and
the rest from the periplasmic domain, including a loop-and-tunnel contacting site
(Figure 4.1B). The interaction between TH1 (blue) from one subunit and TH8 (yellow)
of the neighboring subunit is highlighted in Figure 4.1C, with residues lining the intersubunit interface shown as ball-and-stick models.

The interaction between the protruding loop from one subunit and multiple residues
that form a tunnel around the loop from the other subunit is the major contributor to the
binding interface in AcrB, contributing ~47% of the overall decrease of ASA. Among
amino acids in the loop sequence, three residues are Ala, Ala215, Ala216, and Ala232
(Figure 4.2A). In a previous study, we conducted an Ala scanning experiment, mutated
each non-Ala residue in the loop into Ala, and measured their drug efflux activity.157
We identified five residues in the loop that when replaced with Ala, the mutant
displayed decreased substrate efflux activity. These residues are Gly217, Leu219,
Gly220, Pro223, and Leu230 (Figure 4.1B). None of other residues in the loop was
sensitive to Ala mutation. Therefore, mutants containing Ala at these five positions
were chosen for this study. In addition, we have also included AcrBP224G. P224
immediately follows the invariable residue P223. While the activity of AcrBP223G was
close to that of the negative control, the activity of AcrBP224G was comparable to that
of the wild type AcrB.158 AcrBP224G was used as an example of a drastic change of
amino acid not leading to an observable change of activity.
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To increase the pool of AcrB variants with decreased trimer affinity, we also created
several additional AcrB variants with mutations at the inter-subunit interface in the
transmembrane domain. Although each AcrB subunit contains 12 THs, only a few
residues from TH1 and TH8 which are close to the cytoplasmic side of the membrane
are involved in inter-subunit interaction (Figure 4.1C). Based on the analysis of the
crystal structure as well as sequence alignment result, we chose to mutate three
invariant residues, Leu886, Glu893, and Trp895, in TH8 into Gly (Figure 4.2B). No
mutational study was conducted in TH1 due to concerns that mutations in TH1 might
interfere with membrane insertion. To create partially active mutant with defect in
TH1-TH8 packing, we trimmed down the size of the side chains of these three residues
by replacing them with Gly. We constructed single as well as double and triple mutants
involving these residues.
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Figure 4.2 Sequence alignment of residues in the loop (A) and TH8 (B), residues at the
interface are shown as white fonts in black box). Numbers indicate the position of the
starting and ending residues in the sequence of E. coli AcrB. Asterisks, colons and
periods indicate identical, conserved and semi-conserved residues, respectively. The
sequences are: EC, AcrB from E. coli; PA, MexB from Pseudomonas aeruginosa; NM,
MtrD from Neisseria meningitidis; HC, HcanM9_00968 from Helicobacter canadensis;
SE, acridine efflux pump from Salmonella enterica; LL, AcrB from Legionella
longbeachae; SM, HAE1 from Tenotrophomonas maltophilia; MC, AcrB from
Moraxella catarrhalis RH4.

4.3.2 AcrB variants displayed partial or full activities
To determine the effect of mutations on protein activity, we measured activities of
AcrB constructs using both drug susceptibility and ethidium bromide (EtBr)
accumulation. Drug susceptibility was performed as described.133 Briefly, E. coli
strain BW25113ΔacrB was transformed with plasmids encoding the indicated AcrB
constructs. The same bacterial strain containing plasmid encoding wild type AcrB or
the empty cloning vector pQE70 was used as positive and negative controls,
respectively. MIC was measured under the basal expression conditions. Four well
established AcrB substrates, erythromycin (Ery), novobiocin (Nov), rhodamine-6-G
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(R6G), and tetraphenylphosphonium (TPP) were chosen to represent the diversity of
AcrB substrates of different polarity, structure, and charges. In addition, the presence
or absence of AcrB causes a large MIC change for these drugs (ranging from 32-to
128-fold), which provides a wide dynamic range to reveal differences between the
residual levels of activities of different mutants (Table 4.1). As shown in Table 4.1,
AcrB tolerated mutations at the TM interface much better than mutations in the loop.
In several cases a single mutation in the loop had a more dramatic effect on the activity
of AcrB than the simultaneous mutation of three invariable residues in TH8.
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Table 4.1 MIC and EtBr accumulation rate of BW25113acrB containing plasmid
encoding the corresponding protein, and monomer stability of AcrB constructs.
Protein

MIC (µg/ml)
Ery Nov R6G TPP

EtBr
Transition
accumulation
point (XSDS)
rate (s-1)
No AcrB*
2.5
5
5
5
1.4×10-1
/
-3
AcrB
80 160 320 640
8.9×10
1.6±0.1
AcrBG217A
10
40
80
80
/
/
AcrBL219A
5
20
20
10
/
/
AcrBG220A
5
40
80
20
/
/
AcrBP223G
5
10
20
20
/
/
AcrBP223A
10
40
40
40
/
/
AcrBP224G
80 160 320 640
/
/
AcrBL230A
5
20
20
10
/
/
-2
AcrBL886G
80 160 320 640
1.1×10
1.5±0.1
AcrBE893G
80 160 320 640
7.6×10-3
1.5±0.1
-2
AcrBW895G
80 160 320 640
1.0×10
1.5±0.1
AcrBL886G/E893G
40
40
320
40
4.9×10-2
1.4±0.1
-2
AcrBE893G/W895G
40
40
320
40
2.3×10
1.5±0.1
AcrBL886G/E893G/W895G 20
10
160
20
8.3×10-2
1.5±0.1
*: BW25113acrB transformed with the empty vector pQE70 was used as the negative
control for activity.

To confirm that the increased drug susceptibility was due to a slower active efflux, we
examined the substrate efflux rate of AcrB constructs using EtBr accumulation.
Accumulation of EtBr by live E. coli cells was monitored by following the increase of
fluorescence of EtBr.153 Accumulation rate was inversely correlated with the capacity
of efflux pumps transporting EtBr out of bacterial cells. EtBr is a substrate of AcrB
and the EtBr accumulation has been used in several studies to reveal the activity of
AcrB.153, 159, 160 We measured the accumulation rate of BW25113ΔacrB containing
plasmid encoding AcrB with mutations in the transmembrane interface. The strains
containing plasmids encoding AcrB with mutations in the loop were not included in
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this measurement, since we observed changes in the stabilities of individual monomers
due to those mutations (the result was published recently).151

The same strain

containing plasmid encoding wild type AcrB or the empty cloning vector pQE70 were
used as positive and negative controls, respectively. As shown in Table 4.1, removal
of AcrB led to approximately 16-fold increase in the accumulation rate. In the triple
mutant, the accumulation rate was approximately 10-fold that of cells containing wild
type AcrB. The increase of accumulation was consistent with the observed decrease of
MIC in strains expressing AcrB mutants.

Neither MIC nor EtBr accumulation directly measures the drug efflux rate. They
reflect the combined effects of the drug entering the cell, mainly via diffusion, and
exiting via active efflux and passive diffusion. We have also attempted to measure
AcrB activity directly using the recently developed Nile Red efflux assay.154 We found
that the difference between the positive (0.03±0.01 s-1) and the negative controls
(0.02±0.01 s-1), BW25113ΔacrB containing wild type AcrB or no AcrB, was not large
enough and the resolution was not high enough to resolve the differences in efflux
activities among different mutants.

4.3.3 Most AcrB variants used in this study have similar expression levels
We measured the relative expression levels of all mutants used in this study. Plasmids
encoding different AcrB constructs were transformed into BW25113ΔacrB for protein
expression under the basal condition. Detergent-dissolved cell membrane samples
obtained from freshly prepared log phase cells were analyzed using SDS-PAGE and
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Western Blot analysis (Figure 4.3). The expression levels of all mutants were similar
to the expression level of wild type AcrB except for AcrBE893G, which appeared to have
a significantly higher expression level. Although it was not clear why the expression
level of AcrBE893G was higher, these results indicated that the increased drug
sensitivities and EtBr accumulation rates of E. coli strains that expressed AcrB mutants
was not a result of reduced AcrB expression.
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Figure 4.3 Western blot analysis of expression levels of all AcrB constructs. A. Image
of representative blots. B. Expression of AcrB mutants normalized to the expression
level of the wild type AcrB. Experiments were performed three times. The average
value and standard deviation are shown.
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4.3.4 Mutations introduced in TH8 had little influence on the structure of monomers.
The interaction between the protruding loop from one subunit and residues that
collectively form a tunnel around the loop from the other subunit is the major
contributor to the binding interface in AcrB. However, mutations in the loop or the
tunnel that lead to changes of efflux activity have been shown to affect the stability of
individual monomers.151 To confirm whether mutations in the transmembrane domain
would alter individual monomers, AcrB mutants were purified and examined using CD
spectroscopy and fluorescence emission spectroscopy. As shown in Figure 4.4, all
mutants had similar CD spectra as that of the wild type AcrB, suggesting that mutations
in the transmembrane interface had little influence on the overall protein structure.
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Figure 4.4 CD spectrum of each AcrB construct (grey) superimposed onto the spectrum
of wild type AcrB (black). All mutants had similar overall structure as that of the wild
type AcrB.

Furthermore, we performed SDS-induced denaturation monitored by intrinsic
fluorescence. We previously showed that the sharp decrease of fluorescence observed
was most likely due to the unfolding of monomers,151 which was further confirmed by
the observation that the unfolding profile and the molar ratio of SDS (XSDS) at the
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transition point Tm was not affected by the introduction of an inter-subunit disulfide
bond (C225-C777), which strengthened trimer association via a covalent bond (Figure
3.3 in Chapter III). Here we used this method to study the monomer stability in each
AcrB construct. The denaturation profiles of all mutants tested were very similar to
the profile of the wide type AcrB. Figure 4.5A shows the unfolding profiles of AcrBWT
and the mutants. The transition point was calculated for comparison by fitting the curve
with a single exponential equation as described in Materials and Methods section
(Table 4.1). There was no drastic change in transition point in all mutants, suggesting
that the mutations we introduced did not significantly disrupt the stabilities of AcrB
monomers.
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Figure 4.5 Stability characterizations. A. SDS induced unfolding profile of wild type
AcrB (black diamonds) and AcrBL886G/E893G/W895G (grey squares) monitored by
fluorescence emission. The curves showed the fitting using a single exponential
equation. B. SDS induced unfolding profile of wild type AcrB (black diamonds) and
AcrBL886G (black triangles), AcrBE893G (open triangles), AcrBW895G (open circles),
AcrBL886G/E893G (black crosses), and AcrBE893G/W895G (open squares). Curves of fitting
were omitted for visual clarity.
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4.3.5 Determination of the trimer association constant of purified AcrB variants
In the equilibration between AcrB monomer (M), dimer (D), and trimer (T):
K1
K2
2M 
D, D  M 
T

The apparent trimer association constant Kapp is:

K app  K1K 2 

MD
MT
M

 T 3 (Eq. 4. 1)
2
M M M DM M M M

in which MT, MD, and MM are the molar concentrations of trimer, dimer, and monomer,
respectively. For detergent solubilized membrane proteins, the actual volume that a
protein can occupy is limited by the volume defined by detergent micelles.161,
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Therefore, a mole fraction concentration of protein versus detergent is a more proper
expression of the association constant of AcrB trimer in detergent micelles:
nT
KX 

(n M

n Det
n Det

(Eq. 4.2)
)3

in which nT, nM and nDet are moles of trimer, monomer, and detergent, respectively.161
The relationship between KX and Kapp is:

nT
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M
2
2
 T 3  nDet  [ T
 3 ]  [ Det2  V 2 ]  T 3  M Det 2  K app  M Det
3
(nM / V ) V
V
MM
)3 nM
(Eq. 4.3)

in which V is the total volume, and MDet is the molar concentration of detergent. Using
this equation, we estimated and compared relative trimer stability of AcrB mutants.
BN-PAGE was used to estimate the trimer to monomer ratio, and thus their
concentrations in the sample. BN-PAGE is a well-established method that has been
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used broadly in the characterization of membrane protein oligomers.137, 163 All AcrB
constructs migrated as a mixture of trimer and monomer. The positions of AcrB
monomer and trimer in BN-PAGE have been previously established.133, 136 No dimer
band was observed in any AcrB construct, indicating that the portion of dimer was
negligible and therefore neglected during calculation. The concentrations of AcrB
monomer and trimer were obtained by multiplying the total AcrB concentration in the
sample by the percent of AcrB existed as monomer or trimer, respectively. A trimer
association constant KX was calculated using Equations 4.2 and 4.3 from the
concentrations of detergent, and AcrB monomer and trimer (Table 4.2). The relative
affinity, Kr, is the ratio between the KX of each mutant and the KX of the wild type
AcrB. The free energy of trimer association of the wild type AcrB was calculated from
KX using the equation ΔGX=-RTln(KX), which was -11.9±0.8 kcal/mol. The free
energy difference of trimer association, ΔΔGX, was calculated from Kr. Representative
BN-PAGE gel images were shown in Figure 4.6.
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Table 4.2 Trimer stabilities of AcrB constructs.
Protein

KX

AcrB

(6.6±3.2)×108

AcrBL886G

ΔΔGX (kcal/mol)

Kr
6

(3.8±2.1)×10

7

1

/
-3

3.1

-3

5.8×10

AcrBE893G

(3.0±0.8)×10

4.5×10

1.8

AcrBW895G

(3.0±0.9)×105

4.6×10-4

4.6

AcrBL886G/E893G

(1.8±0.6)×105

2.8×10-4

4.8

AcrBE893G/W895G

(1.7±0.9)×105

2.6×10-4

4.9

AcrBL886G/E893G/W895G

(1.9±1.0)×105

2.8×10-4

4.8

Figure 4.6 BN-PAGE gel of purified AcrB constructs. Positions of monomer and
trimer bands are marked by M and T, respectively.
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4.3.6 Correlation between AcrB trimer stability and transport activity.
To quantitatively review the relation between the relative trimer stability of a mutant
and its biological activity, we plotted the relative trimer affinity (Kr) of each mutant in
detergent micelles versus the MIC (Figure 4.7A) and EtBr accumulation rate (Figure
4.7B) of wild type AcrB and its variants (only the AcrB constructs with mutations in
the transmembrane interface). Relative trimer affinity Kr was obtained by designating
the affinity of wild type AcrB as 1 (Table 4.2). Data for all substrates showed the same
trend. The correlation between the trimer stability and drug efflux activity was clearly
not linear.

To compare efflux activity measured using MIC and EtBr accumulation, we
normalized MIC values for four substrates and EtBr accumulation rates to obtain the
residual percent activity. Various substrates are intrinsically different in their binding
affinities and interactions with AcrB. Therefore it was not surprising that the fold
change on MIC and accumulation rate caused by the same mutation were not always
the same. However, an overall trend could be observed, in which a mutant with lower
activity transported all substrates with lower efficiency (Table 4.1). These residual
activities were plotted against the relative trimer stability for seven AcrB constructs
examined in this study (Figure 4.7C). The switch from no function to full function
occurred in a very narrow stability range. The threshold trimer stability was required
for efflux activity. This threshold value in terms of relative affinity is approximately
0.001, or three orders of magnitude lower than the affinity of the wild type trimer.
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Figure 4.7 Correlation between AcrB trimer affinity and substrate efflux activity. A.
MIC of four different AcrB substrates determined for BW25113ΔacrB containing
plasmid-encoded wild type AcrB or AcrB mutants plotted against their relative affinity.
Substrate for each plot is indicated. B. EtBr accumulation rate of BW25113ΔacrB
containing plasmid-encoded wild type AcrB or AcrB mutants plotted against their
relative affinity. C. Normalized MIC values and EtBr accumulation rate (diamonds)
plotted against the relative trimer affinity. Substrates tested were Ery (open squares),
TPP (black triangles), R6G (open diamonds), and Nov (black crosses).
accumulation data are shown as open triangles.
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EtBr

4.4 Discussion
Accurate determination of the oligomer’s association constant of proteins in the cell
membrane remains very challenging. Here we examined the correlation between the
relative oligomer association affinity of purified AcrB mutants in detergent micelles
and their biological activity. We have to acknowledge the limitations of the method
used in this study. During the purification process, membrane protein was transferred
from a native biological bilayer membrane environment to a less favorable detergent
micelle environment. The transfer might cause a certain degree of reduction in trimer
amount. The association constant that we obtained using purified AcrB in DDM
detergent micelles might also be very different from the actual association constant in
cell membrane. It is generally believed that the oligomer affinities of membrane
proteins are much higher in phospholipid bilayers than in detergent micelles. For
example, in two studies the association constants of model transmembrane helices are
found 100-fold stronger in lipid bilayers than in detergent micelles.164, 165 In addition,
the relative trimer and monomer content in each mutant was estimated using BN-PAGE.
BN-PAGE is a non-equilibrium method. During electrophoresis, the trimeric species
and monomeric species are physically separated, which may cause more trimers to
dissociate during the process and lead to a negative bias in the measured association
constants. However, we speculate that a similar trend as we observed here likely exist
between the trimer stability of AcrB in the actually cell membrane and its substrate
efflux activity.
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The first important observation of this study is that the stability-activity correlation
was not linear. The trimer stability of an AcrB mutant needed to reach a threshold
value for the protein to display activity. A drastic increase of activity occurred within
a narrow range of trimer stability. To discuss the affinity in the thermodynamic energy
terms, we calculated the free energy difference of trimer association (ΔΔG X) from the
relative association constant Kr (Table 4.2). When measured in the current system in
detergent-dissolved state, this threshold value was approximately 5 kcal/mol. In other
words, the association energy of the wild type trimer was 5 kcal/mol higher than the
threshold value. We also calculated the free energy of trimer association of the wild
type AcrB, which was approximately 12 kcal/mol. The value is in good agreement
with membrane protein oligomerization energetics reported in the literature.
Association energies have been determined for a few model membrane proteins and
peptides in detergent micelles and phospholipids (Table 4.3).

Glycophorin A

transmembrane fragment (GpATM) was used as the model protein in three such studies,
while fibroblast growth factor receptor 3 (FGFR3) and the transmembrane fragment of
the M2 protein from influenza A virus were used in the other two studies. All model
proteins form single transmembrane helices. Both GpATM and FGFR3 dimerize, while
the M2 protein fragment forms a tetramer. The dimerization energy of GpATM in
detergent micelles is 7 kcal/mol. The association constant for the tetrameric M2 protein
fragment is determined to be 2×106 in detergent micelles, corresponding to an
association free energy of 8.6 kcal/mol. The larger association energy of the wild type
AcrB trimer (approximately 12 kcal/mol) could arise from the larger intersubunit
interface in AcrB as it is a much larger protein than the models. For both soluble and
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membrane proteins, the oligomerization free energy per subunit are quite modest, that
might

be

necessary

to

maintain

flexibility

of

protein

structure

and

association/dissociation state to suit functional requests. Changes in the quaternary
state often affect a protein’s biological function or activity, therefore stability of
protein-protein interactions in such complexes is an important regulator for biological
functions.135, 142, 143, 166-169

On a final note, substrate efflux facilitated by AcrB was measured as readout of AcrB
activity. While we cannot completely rule out the possibility that the mutations studied
affected substrate efflux via additional mechanisms such as substrate binding, proton
relay, or interaction with AcrA/TolC, such possibilities are not very likely since the
residues mutated were distant from these sites.
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Table 4.3 Oligomer association constant and energy reported in literature.
System

Method

KX

ΔGX

Glycophorin A transmembrane
fragment (GpATM) in
detergent micelles125, 161

Analytical
ultracentrifugation

/

-7 kcal/mol

Transmembrane fragment of
the M2 protein from influenza
A virus in detergent micelles
and phospholipid bilayer164

Thiol-disulfide
equilibrium

2×106 in
detergent
micelles
2×108 in
lipid
bilayer

/

Fibroblast growth factor
receptor 3 (FGFR3) in
phospholipid bilayer170

FRET

/

-3 kcal/mol

GpATM in vesicles derived
from mammalian cell
membranes171

Quantitative
Imaging FRET

/

-3.9±0.2*
kcal/mol

GpATM in detergent micelles
and phospholipid bilayer165

Steric trap

/

-7 kcal/mol
in detergent
micelles
-12 kcal/mol
in bilayer

*Standard state was defined as KD=1 per nm2.

4.5 Conclusion
The majority of membrane proteins function as oligomers. However, it is not yet clear
how the oligomer stabilities of these complexes correlate with their function.
Understanding of the relationship between oligomer stability and activity is essential
to protein research, and to virtually each and every cellular process that depends on the
function of protein complexes. In this study, we obtained one of the first set of data
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describing a direct correlation between the oligomer association constant and activity
of a multiple spanning helical membrane protein. A non-linear correlation between
AcrB trimer affinity and transport activity was observed, in which a threshold trimer
stability was required to maintain efflux activity. Once the threshold was met, further
increase of stability in the range observed had no observable effect on protein activity.

Copyright © Cui Ye 2014
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CHAPTER V. MOLECULAR ENGINEERING OF AQUAPORIN Z
5.1 Introduction
Over 30% of the world’s population lives in countries facing water shortage. This
figure is predicted to double in 2025.172-174 The overall fresh water storage on our
planet is a largely fixed number. The only methods that can increase the usable fresh
water supply beyond what is available from the water cycle are desalination of sea
water, purification of ground water, and recycling of waste water. All these methods
depend on the availability of efficient techniques to separate water from solutes and
insoluble substances co-existing with water. The traditional process for desalting is
distillation (i.e., the boiling of water), such as multi-effect distillation (MED) and
multistage flash (MSF).175-178 The membrane based desalting techniques, principally
the reverse osmosis technology, are currently most applied method to separate water
from salts with a lower energy cost than thermal distillations.179 In the reverse osmosis
desalting system, an applied pressure is used to overcome the osmotic pressure to drive
water molecules through a semipermeable membrane and thus separate them from
other chemical species.

However, the low water permeability of the synthetic

membrane currently used in the reverse osmosis diminishes their performance.178
Therefore, the development of a synthetic membrane with a high water permeability
becomes a hot topic in this area.

Biological membranes have an efficient water transportation system that allows water
molecules to rapidly cross the hydrophobic membrane bilayer. The movement of the
water molecules is facilitated by specific water channels (also called aquaporins)
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embedded in the cell membrane, as discovered by Peter Agre in 1992.180 Aquaporins
are found in almost all organisms and are especially rich in the organisms with a strong
ability to regulate the permeability.181-183 Aquaporins give high water permeability and
selectivity to biological membranes. Aquaporin Z (AqpZ) is an integral membrane
protein discovered a decade ago as an effective water channel in E. coli.184 Studies
showed that the expression of AqpZ cRNA yielded Xenopus oocyts with a 15-fold
increase in the osmotic water permeability, but failed to transport nonionic solutes such
as urea and glycerol.184 Due to its superb specificity and high permeability, AqpZ has
been incorporated into artificial membranes used for water filtration and
desalination.185-187

In this study, we attempt to develop molecular engineering

strategies to improve the stability of AqpZ, so that it can work under the high pressure
and high salinity when used in water purification.

AqpZ forms a symmetric tetramer in the cell membrane, with each monomer acting as
an independent water channel (Figure 5.1). Each AqpZ monomer is made up of six
transmembrane α-helices forming a right handed bundle.188 The high-resolution crystal
structure of AqpZ suggested that the channel is long (approximately 28 Å in length)
and narrow (less than 4Å in diameter). AqpZ acts as a two-stage filter. The first stage
with two highly conserved NPA (Asn-Pro-Ala) motifs forms a very narrow pathway
(the narrowest point with a diameter of approximately 2 Å), and excludes most of the
solutes due to the steric hindrance. The second stage (aromatic/arginine region) is
proposed to repel positive charged ions (such as protons, hydronium) by arginine.189
Native AqpZ tetramer is a highly stable complex and can maintain its oligomeric state
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even in 1% SDS at neutral pH. In this work, we tested several molecular engineering
approaches to stabilize the AqpZ structure and estimated the stability of the mutants by
CD spectroscopy. Our results indicated that the structure of AqpZ is intrinsically stable
and none of the mutation tested in this work has significantly improved its thermal
stability. Additional investigation of the factors stabilizing AqpZ may reveal the
molecular interactions critical for the AqpZ stability, which may be applicable to
stabilize other membrane proteins.

Figure 5.1 Structure of AqpZ (created from 2ABM.pdb19 using Pymol18). A. Top view
of AqpZ tetramer. Each subunit has a water conducting channel in the center of the
helix bundle. B. Side view of one AqpZ subunit.
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5.2 Materials and Methods
5.2.1 Plasmid construction, protein expression and purification
Genes encoding AqpZ was amplified from the genomic DNA of E. coli K-12 and
inserted into plasmid pET28a between two restriction enzymatic sites (NdeI and XhoI).
A six-histidine tag was introduced at the N terminal of protein for the convenience of
the protein purification. Complementary primers used in the construction of expression
plasmids were as follows: 5’-CATATGTTCAGAAAATTAGCAGCTGA
-ATGTTTTGG and 5’-CTCGAGTTAATCACGCTTTTCCAGCAGGGTC with
restriction enzymatic sites underlined. Mutations were introduced into the aqpZ gene
in plasmid pET28a-AqpZ using the QuikChange Site-Directed Mutagenesis Kit
following the manufacturer’s instructions (Agilent Technologies) and confirmed
through DNA sequencing. Plasmid containing aqpZ gene or its mutations was then
transformed into E. coli strain C43 for protein expression.

Cells were cultured at 37 °C in Lysogeny Broth media containing 50 g·mL-1
kanamycin to an OD600nm of approximately 0.6. Protein expression was induced by the
addition of IPTG to a final concentration of 1 mM. After three hours at 37 °C, cells
were harvested by centrifugation at 7,000 g for 10 min at 4 °C. Cell pellets were stored
at -20 °C before purification. AqpZ was purified following the published protocol for
AcrB with minor modifications.135 In the elution step, the elution buffer contained 0.25
M imidazole, 0.03% DDM, 20 mM Na-phosphate, 0.3 M NaCl, pH 7.9. Protein
samples were dialyzed overnight against the same buffer without imidazole at 4°C.
The same buffer was used throughout this study unless otherwise noted.
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Purified protein was analyzed by SDS-PAGE and visualized after the gels were stained
using Coomassie Blue. Protein concentration was determined using Pierce BCA
Protein Assay Kit (Thermal Scientific INC., TX).

5.2.2 Quantification of the disulfide bonds formed in AqpZG91C
The efficiency of disulfide bond formation in AqpZG91C was evaluated following a
published protocol with minor modifications.135 The entire process consists of three
steps: the blockage of the free cysteines, the reduction of the disulfide bonds, and
fluorescent labeling. Briefly, the purified protein was treated with iodoacetamide (IAM)
and SDS at the final concentrations of 10 mM and 4% (w/v), respectively, for 30 min
at 37°C. IAM blocks the free Cys residues, but has no effect on the disulfide bonds.
After the blockage, DTT was added to the mixture to a final concentration of 50 mM
to break the disulfide bonds into free thiols. After 1 h incubation at 37°C, protein was
precipitated using 15% trichloroacetic acid (TCA). After centrifugation, the precipitate
was washed with cold acetone and then resolublized in a buffer solution containing 4%
SDS and 50 mM Tris (pH 8.0). The precipitation and washing steps removed DTT
from the protein sample. The freshly generated thiol groups were immediately labeled
using 5mM 5-maleimido-fluorescein (F-MAL). The labeling reaction was incubated
at room temperature for 15 min before it was stopped by the addition of 50 mM of DTT.
The protein sample was subjected to SDS-PAGE.

After the remaining free

fluorescence dye migrated out of the gel, the gel was removed and the fluorescence
image was taken under the UV light. The same gel was then stained using Coomassie
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blue stain and the image of the gel was taken again under normal white light. Positive
and negative controls were performed without the absence of the blockage or the
reduction step.

Gel images were analyzed using software ImageJ to obtain the

percentage of the disulfide bonds.93 Assuming that all Cys have the same labeling
efficiency, fraction of Cys involved in the formation of the disulfide bonds was
calculated using following equation:
𝐹=

𝐹𝑠
2
𝐹𝑃 × 3

where 𝐹 is the fraction of Cys that formed disulfide bonds; 𝐹𝑠 and 𝐹𝑃 are the
fluorescence intensities of the sample and positive control, respectively.

2
3

indicates

that two out of three Cys in AqpZG91C could potentially form a disulfide bond.

5.2.2 Protein thermal denaturation monitored using CD spectroscopy and fluorescence
spectroscopy
CD spectra and thermal denaturation experiments were conducted on a JASCO J-810
spectrometer following a published protocol.136 Purified wild type AqpZ was first
treated with different concentrations of urea (0, 4 M, 6 M, and 8 M). After incubation
at 4°C for 30 min, ellipticity at 222 nm of protein sample was measured as temperature
was increased from 40°C to 100°C with a temperature interval of 1°C/min. Spectral
scans were collected at 40°C and 100°C in the wavelength range between 210 to 250
nm. The CD signals below 210 nm could not be obtained due to the presence of urea.
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Thermal denaturation of the purified AqpZ was monitored by intrinsic tryptophan
fluorescence by a LS-55 fluorescence spectrometer (PerkinElmer, Inc., Waltham, MA).
The decrease of the intensity of fluorescence emission was recorded at the excitation
wavelength of 280 nm as the temperature increased from 20°C to 80°C.

5.3 Results and Discussion
5.3.1 A rational design of positions to be mutated
We used two methods to improve the intrinsic stability of AqpZ: one was the
introduction of proline into β-turns, and the other was the introduction of a disulfide
bond into AqpZ monomer by site directed mutagenesis. Pro is commonly found in βturns, due to its rigid backbone structure.190, 191 An increase of conformational entropy
is one of the major forces driving protein unfolding. To stabilize their structure,
proteins prefer a residue with a rigid side chain (such as Pro) to one with a flexible side
chain in their β-turn structure to minimize the entropy gain of the unfolding. The
majority of naturally occurring membrane proteins do not have their stability highly
optimized. This is likely due to a certain degree of the flexibility required for
conformational change. One of our approaches to improve the stability of AqpZ was
to replace flexible amino acid residues with a more rigid Pro residue. Several studies
have shown that the introduction of Pro into β-turns is an effective way to stabilize the
protein tertiary structure, especially if Pro is introduced at the secondary site (i + 1) in
a β-turn (Figure 5.2A).192-195 AqpZ contains eight -turns (Figure 5.3). Three of the
eight -turns contain Pro at the i+1 position (turns number 1, 5, and 8). We replaced
the i+1 residues in two (T107 and A27) out of other five -turns with Pro to examine
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whether the method would improve the stability of AqpZ. Since the residue is not
conserved, we speculated that such mutations would not affect the structure and
function of AqpZ.

Figure 5.2 -Turns and their presence in AqpZ structure. A. The backbone trace of a
representative -turn from AqpZ (residues K106 to F109). The carbonyl of residue i
forms a hydrogen bond with the amine of i+3. B. The ribbon diagram of an AqpZ
monomer (1RC2.pdb188). Backbone trace is shown for stretches that form -turns, with
the -turn formed by K106 to F109 as shown in A.
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Figure 5.3 Sequence alignment of AqpZ with its homologues with known structures.
Asterisks, colons and periods indicate identical, conserved and semi-conserved
residues, respectively. Positions of -turns in the structure of AqpZ are highlighted by
the numbers on top of the AqpZ sequence. Of the 8 -turns in AqpZ, three intrinsically
contain Pro at the i+1 position (turns number 1, 5, and 8). The corresponding structure
files in the protein data bank for the proteins used in the alignment are: 1R2C.pdb for
AqpZ,188 1YMG.pdb for Aqp0,196 1FQY.pdb for Aqp1,197 2F2B.pdb for AqpM,198 and
1FX8.pdb for GlpF.199

The introduction of disulfide bonds is another simple and effective strategy that could
be used to improve the protein tertiary stability by creating new linkages between
neighboring helices. There are two intrinsic Cys in the sequence of AqpZ, C9 and C20
(Figure 5.4A), both existing as free sulfhydryl groups. While the side chain of C20
points to the water transduction channel, the side chain of C9 is exposed to the lipid
bilayer. We took advantage of C9, which is within the disulfide bond distance to two
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residues from neighboring helices, A87 and G91 (Figure 5.4B). We replaced A87 or
G91 with Cys and expected that the introduced disulfide bond would enhance the
interaction between the neighboring helices. In addition, since the function of AqpZ
does not involve a large-scale conformational change, we expect the introduction of a
disulfide bond at a location distant from the water conducting channel should have a
minimum impact on activity.

Figure 5.4. Ribbon diagram of AqpZ monomer structure (1RC2.pdb188). A. Top view
of the structure with positions of the two intrinsic Cys highlighted using space filled
model. B. Side view of the structure with positions of C9 and two residues close to C9
in space, A87 and G91.
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5.3.2 None of mutations increased the thermal stability of AqpZ
To assess the effect of mutations on the stability of AqpZ, we conducted temperatureinduced denaturation monitored by far UV CD spectroscopy. As described in previous
chapters, CD is one of most general and basic tools to study protein unfolding, in which
a melting temperature (Tm) could be determined as a measurement of the thermal
stability of a protein. For α-helical proteins, an increase of temperature disrupts
structures of the protein, resulting in a drop of CD signal at two characteristic negative
peaks (208 nm and 222 nm) (Figure 5.5A). Protein unfolding thus could be observed
by following the decrease of CD signal at 222 nm. The denaturation profile of wild
type AqpZ (Figure 5.5B) was obtained. A high Tm (approximately 94°C) suggested
the high thermal stability of AqpZ.

Figure 5.5 Thermal denaturation of AqpZ monitored using far UV CD spectroscopy.
A. CD spectra of AqpZ at 20°C (filled) and 100°C (open). B. Temperature induced
unfolding profile of AqpZ followed by fixing the wavelength to 222 nm.
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We repeated the denaturation experiment in the presence of urea, a widely used protein
denaturant. CD signals below 210 nm could not be observed because of a very strong
absorption of urea at and below this wavelength.200 The presence of urea up to 8 M
barely affected the secondary structure of AqpZ (Figure 5.6A), but significantly
reduced its thermal stability (Figure 5.6B). Tm of wild type AqpZ decreased by
approximately 10°C and 20°C in the presence of 6 M and 8 M urea, respectively. On
the other hand, the presence of 4 M urea had little effect on the melting temperature.

Figure 5.6 Effect of urea on secondary structure and melting point of AqpZ. A. CD
spectra of AqpZ in the absence (diamonds) and presence of urea at 20°C. B. Thermal
denaturation of AqpZ followed by fixing the wavelength to 222 nm.

Urea

concentrations tested are 4 M (squares), 6 M (triangles), and 8 M (crosses).

CD spectra and temperature scans of all AqpZ mutations were performed in the
presence of 6 M urea. A higher concentration of urea than 6 M significantly increased
the spectral noise. The CD spectra of all AqpZ mutants, except A27P, overlapped with
that of the wild type protein, suggesting that mutations did not alter the overall protein
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structure (Figure 5.7A). The loss of the AqpZA27P secondary structure in the presence
of urea indicated a less stable structure caused by the introduction of the Pro residue.
The temperature-induced unfolding curves of all other AqpZ mutants were obtained
and compared with the wild type protein (Figure 5.7B). The Tm of the protein was not
enhanced by the introduction of the designed mutations.
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Figure 5.7 Thermal stabilities of AqpZ and its mutants measured by CD spectroscopy.
A. CD spectra of AqpZ (grey squares) and its mutants (triangles) at 20°C. Mutations
are indicated in graphs. B. Unfolding profiles of AqpZ (grey squares) and its mutants
(AqpZT107P, circles; AqpZA87C, triangles; AqpZG91C, crosses).
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5.3.3 Disulfide bond formations in AqpZG91C
To confirm that the introduced Cys actually formed a disulfide bond with Cys9, we
monitored the formation of the disulfide AqpZG91C.135 According to the method, cys
involved in the formation of the disulfide bond could be labeled by F-MAL (Figure
5.8B/D, lane 2). Therefore, the presence or absence of the disulfide bond could be
observed by examining the fluorescence labeling. The positive control was the same
protein with all cys labeled by F-MAL (Figure 5.8A/D, lane 1). The negative control
was included to confirm the lack of non-specific labeling to non-Cys sites (Figure
5.8C/D, lane 3). Approximately 50% of C9 and C91 formed a disulfide bond. However,
the introduction of a disulfide bond did not improve the stability of the protein tertiary
structure.
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Figure 5.8 Disulfide bond formation in AqpZG91C. A. Positive control. Purified protein
was incubated with DTT, followed by labeling using F-MAL. All Cys residues in the
protein could be labeled. B. Negative control. Purified protein was treated by IAM
before F-MAL labeling. None of the Cys could be labeled. C. Experimental group.
Purified protein was first treated by IAM, reduced using DTT, and then labeled using
F-MAL. Original free Cys could not be labeled, while Cys protected by a disulfide
bond during the IAM treatment could be labeled after DTT reduction. D. Purified
AqpZG91C was divided into three aliquots, and then treated according to the procedure
described in A (lane 1), B (lane 2), and C (lane 3), respectively. Purified AqpZG91C
contains one free Cys and one disulfide bond. Protein bands analyzed using SDSPAGE was photographed under UV light (top) and then visualized by Commassie blue
stain under white light (bottom).
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5.4 Prospectus
Our results indicated that the thermal stability of AqpZ has been highly optimized. This
is not common for membrane proteins. It was shown by Bowie and co-workers that
the frequency of stability-enhancing mutations is remarkably high for membrane
proteins.118, 201-203 Roughly 10% of random mutants were found to improve the stability
of a membrane protein, indicating the prevalence of the membrane proteins with
moderate stability. Investigation of the mechanism behind the remarkable stability of
AqpZ is a future direction of this project. Knowledge about the stabilizing factors could
be used in rational design efforts to stabilize the membrane proteins used in the
structural determination and therapeutic application.

Searching for a method to

quantitatively assess the overall stability of AqpZ will be a second subproject. In this
study, the protein stability is primarily accessed through measuring the melting
temperature using CD spectroscopy, which reveals the stability of the protein
secondary structure. A more comprehensive evaluation on the entire structure of the
protein is desirable for better understanding its stabilizing factors.

To investigate stabilization factors of AqpZ, the first task is to figure out the reasons
for the membrane proteins instability. One of the reasons is considered to be related to
protein dynamics.204

The operation of many membrane proteins relies on

conformational changes. An increase in the stability may lead to a decrease of the
structural flexibility and a lower activity. Secondly, the stability of the membrane
proteins is usually measured in detergent micelles, not in the natural cell membrane. It
is possible that they have already achieved a degree of stability in the cell membrane
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that is sufficient for cell viability.203, 205 As discussed in Introduction, the selectivity of
AqpZ relies on the size exclusion and electrostatic repulsion in the central pores of
monomers. The transportation of water molecules mediated by AqpZ is driven by the
osmotic pressure generated between the cytoplasm and the environment, suggesting
that AqpZ does not undergo a conformational change to perform its function. This
feature might be one of the prerequisites for proteins with a highly optimized stability.
However, other known aquaporins fold into similar structures and have similar
transport characteristics, but with much lower stabilities.

For example, spinach

aquaporin SoPIP2;1 could only maintain its tetrameric state in a mild detergent like
DDM,206 whereas AqpZ tolerances harsh detergent like SDS up to 1% at neutral pH.207
AqpZ is very hydrophobic and its tetramer appears to be tightly packed.207 Trypsin
failed to cleave at any of amino acids in AqpZ when the protein was reconstituted into
proteoliposomes. Therefore, studies on factors stabilizing AqpZ could start with an
investigation of the interface between AqpZ monomers. The interface between the
monomers in several aquaporins could be calculated and compared using the online
server ProtorP.156 Mutagenesis studies could be performed subsequently to determine
the critical residues and interactions in the subunit association. The tetramer stability
of AqpZ could be determined using both SDS-PAGE and fluorescence polarization
spectroscopy as described in Section 3.3.4.

Another technical difficulty encountered in this study is the lack of a proper method to
monitor the unfolding of the AqpZ tertiary structure. Fluorescence spectroscopy has
been extensively used to evaluate the stability of protein tertiary structure.114, 208, 209
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Thermal unfolding of AqpZ monitored using intrinsic fluorescence emission was
attempted. However, an obvious transition was missing in the unfolding profile (Figure
5.9). A recently reported dye-based fluorescence assay is a potential method to assess
the stability of the tertiary structure of AqpZ.210 This assay is based on the fact that the
dye

N-[4-(7-diethylamino-4-methyl-3-coumarinyl)

phenyl]-maleimide

(CPM)

becomes fluorescent after reacting with a free sulfhydryl group. Cys residues are
frequently at helix-helix interaction site in the transmembrane segment of the
membrane proteins, which makes them ideal sensors for the overall integrity of the
helical membrane protein structure. Those Cys residues protected by the neighboring
helices in the native protein were gradually exposed to the CPM dye as the protein
structure collapses with an increase of temperature or concentration of a denaturant,
resulting in a surge of fluorescence signal. AqpZ unfolding could potentially be
monitored using this CPM based method.

Figure 5.9 Thermal unfolding of AqpZ monitored using intrinsic fluorescence.
Copyright © Cui Ye 2014
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